Track market-moving stories before they get noisy

Tootsie Roll Industries trades at a full valuation near 20x EV/EBITDA, lacking growth drivers or meaningful brand expansion. Falling cocoa prices could deliver a 12% net income boost by late 2026, but sales growth remains limited and volume trends are negative. TR's portfolio is narrow, with little R&D, no significant M&A, and minimal investor communication, relying almost entirely on legacy brands.

Hadron Energy Announces NRC Acceptance of Quality Assurance Program Description for Future Manufacturing License Applications, a First for a Light-Water Microreactor Hadron Energy, Inc. (Nasdaq: HDRN) ("Hadron Energy" or the "Company"), an advanced nuclear technology company, today announced that the staff of the U.S. Nuclear Regulatory Commission (NRC) has issued a final safety evaluation finding Revision 3 of the Company's Topical Report (TR), "Hadron Energy, Inc. Quality Assurance Program Description" (QAPD), acceptable for referencing in its future licensing applications under 10 CFR Part 52.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604951514/en/

The NRC staff's final safety evaluation concludes that Hadron Energy's QAPD complies with applicable NRC regulations and industry standards in support of a future 10 CFR Part 52 application. The acceptance establishes a vetted quality assurance framework spanning the full life cycle of the Hadron Micro-Modular Reactor — including design, manufacturing, construction, operations, and decommissioning — and reflects Hadron Energy's integrated role as designer, manufacturer, and owner-operator.

While it is not a license to construct or operate a reactor, and it does not constitute NRC review, approval, or certification of the Hadron Micro-Modular Reactor design, the NRC’s acceptance of the Topical Report is a foundational, programmatic regulatory milestone. Furthermore, Hadron Energy is the first light-water microreactor company to receive acceptance by the NRC of QAPD.

A rigorous quality assurance program is foundational to the safe and reliable deployment of nuclear technology. By establishing an NRC-vetted quality framework at the pre-application stage, Hadron Energy is instituting the disciplined design, manufacturing, construction, and operational controls that underpin nuclear safety from the outset. The QAPD applies a graded, lifecycle-wide approach in which the level of control for any item or activity is commensurate with its safety significance, reinforcing Hadron Energy's commitment to building and operating its reactors to rigorous, independently reviewed industry quality standards, including ASME NQA-1-2022.

"The NRC staff's acceptance of our Quality Assurance Program Description is a critical milestone for Hadron Energy and the development of our Micro-Modular Reactor," said Sam Gibson, Founder and Chief Executive Officer of Hadron Energy. "A quality assurance program that the NRC staff finds acceptable provides a vetted foundation that we can reference as we advance our licensing strategy, helping reduce duplicative review of previously accepted material in future applications, and most importantly provide the confidence to the company’s conceptual reactor design framework as we move toward the first of a kind deployment.”

Standardizing Future Licensing Pathways

Hadron Energy’s QAPD addresses the full lifecycle of the Hadron Micro-Modular Reactor. The program is based on Appendix B to Title 10 of the Code of Federal Regulations (10 CFR) Part 50 and commits to nuclear industry quality standards, including ASME NQA-1-2022, as endorsed by NRC Regulatory Guide 1.28, Revision 6.

Consistent with standard NRC practice, the NRC staff has requested that Hadron Energy publish the accepted version of the Topical Report within three months of its receipt of the NRC's notification, which Hadron Energy will do. This publicly accessible version will incorporate the NRC's correspondence and final safety evaluation and will carry the official "-A" (designated accepted) suffix following the report identification number.

With the QAPD accepted by the NRC staff, Hadron Energy may cite the accepted program in subsequent licensing applications under 10 CFR Part 52, including a Combined License (COL) or a Manufacturing License, to the extent specified and subject to the limitations and conditions in the safety evaluation. Referencing previously accepted material is intended to avoid repetitive NRC review of that material in future applications.

About Hadron Energy, Inc.

Hadron Energy, Inc. (Nasdaq: HDRN) is an advanced nuclear technology company focused on developing the Halo Micro-Modular Reactor (MMR), a 10 megawatt-electric (MWe) factory-manufactured, transportable light-water reactor. Engineered to deliver continuous, emission-free baseload power and heat with a multi-year refueling cycle, Hadron Energy aims to meet the growing demand for clean, scalable, and rapidly deployable energy solutions. As an integrated designer, manufacturer, and owner-operator, the Company is dedicated to powering a variety of critical sectors, including data centers, industrial facilities and heavy manufacturing, remote communities, and grid stabilization. For more information, visit www.hadronenergy.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding Hadron Energy’s regulatory filings with the NRC, its path to approval of its license application, the design of Hadron Micro-Modular Reactor, and the expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the business combination. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of Hadron Energy in light of their respective experience and perception of historical trends, current conditions and expected future developments as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting Hadron Energy will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the ability of Hadron Energy to continue to meet the Nasdaq listing standards, and that Hadron Energy will have sufficient capital to operate as anticipated. Should one or more of these risks or uncertainties materialize, or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260604951514/en/

The biggest payoff from investing in stocks often comes years down the road, when companies you've invested in have grown larger and become more valuable. There can be some considerable risks involving smaller, unproven businesses, but the upside can also be substantial.

Three stocks that I believe have the potential to be 10-bagger investments in the future are CRISPR Therapeutics (CRSP +0.94%), Green Thumb Industries (GTBIF 0.49%), and Joby Aviation (JOBY 2.19%). Let's take a closer look at these promising stocks.

Image source: Getty Images.

CRISPR Therapeutics CRISPR Therapeutics has a market cap of right around $5 billion, and it admittedly hasn't been a great investment over the past five years -- it's down more than 60% over that stretch. The good news is that the gene-editing company has become safer to invest in, and things may look better for CRISPR in the future.

In late 2023, the company obtained approval for Casgevy, a gene-editing therapy it has developed with Vertex Pharmaceuticals. It's approved for treating sickle cell disease and transfusion-dependent beta thalassemia. Casgevy, however, is still in its early stages of rolling out to patients throughout the world, and its full-year revenue totaled just $116 million in 2025. But it could generate billions at its peak. Meanwhile, CRISPR is also working on other treatments, including one for Type 1 diabetes, which could open up even more growth potential for the business in the long run.

Today's Change

(

0.94

%) $

0.47

Current Price

$

50.70

Although CRISPR incurred a loss of $582 million last year, with around $2 billion in cash and marketable securities, its operations are well funded and put the company in a strong financial position. There's some risk with the stock, but overall, it looks to be on a promising trajectory, and CRISPR has the potential to be a much more valuable healthcare company in the future.

Green Thumb Industries A stock that's struggled even worse than CRISPR in the past five years is Green Thumb Industries, which is down more than 70% over that time frame. The cannabis company has been growing, but the problem is that without meaningful reform in the industry, it's been difficult for the business to win over investors.

Marijuana remains illegal federally, but the hope is that it might change in the long run. The government recently rescheduled many medical marijuana products from a Schedule I classification to Schedule III, in what's a significant milestone for the industry. Recreational products may be rescheduled later this year, which may be an even bigger catalyst for pot stocks.

Today's Change

(

-0.49

%) $

-0.04

Current Price

$

8.19

Green Thumb is already one of the safer stocks to own in the cannabis industry. Unlike many others, it has actually turned a profit over the past four quarters. In 2025, it reported net income of $114 million on revenue of just under $1.2 billion. If regulation opens up more opportunities in the cannabis sector, this is a stock I have little doubt could generate 10x returns for investors in the long run. Currently, its market cap is just under $2 billion.

Joby Aviation Another stock that isn't doing as well as investors may have hoped is Joby Aviation. It's only down 14% in five years, but since the start of 2026, its shares have nosedived by 35%. It's a promising player in the emerging electric vertical take-off and landing (eVTOL) market, and it's hoping to obtain approval for its air taxi in the near future.

Joby's valuation remains fairly high at over $8 billion for a company that still hasn't launched commercial operations. It has been generating revenue, but that's been primarily due to a recent acquisition of Blade Urban Air Mobility. If Joby can get its core business off the ground, that's the big catalyst investors are waiting for.

Today's Change

(

-2.19

%) $

-0.20

Current Price

$

9.15

There are, however, still concerns around long-term profitability and whether the business has the potential to scale effectively without just burning through tons of cash along the way. I'm not convinced it can. However, if Joby's business starts generating significant revenue, that may be enough to win over growth investors and to send the eVTOL stock soaring.

Joby may be the riskiest stock on this list, but it's also the one that could command the highest valuation in the long run, given its popularity among retail investors.

Predicting what may or may not happen in the cannabis market isn't for the faint of heart. The industry continues to face several challenges. A quick look at the charts of some of the largest marijuana stocks over the last couple of years proves it.

However, my heart is feeling quite stout these days, so I'll step out on a limb with a prediction. I think Green Thumb Industries (GTBIF 0.49%) stock will double over the next three years. Ridiculous? Not really.

Image source: Getty Images.

About as blue chip as it comes in the U.S. cannabis industry While there aren't any true blue chip stocks in the U.S. cannabis industry, Green Thumb Industries is about as blue chip as you'll find. Its revenue continues to grow despite the aforementioned industry headwinds. The company consistently generates positive earnings and EBITDA. Its gross margins are strong.

Green Thumb's balance sheet is solid, too. At the end of 2025, the multistate cannabis operator had a cash position of $274.3 million. Its total debt was $244.9 million, including $142.5 million of senior debt. Granted, the company has subsequently expanded its syndicated credit facility by $50 million, but at a low rate.

The cannabis markets in which Green Thumb operates are among the most attractive in the U.S. Its 100+ RISE retail dispensaries are focused in states, including Illinois, Maryland, Massachusetts, Ohio, Pennsylvania, and Florida, that limit licenses, which reduces competition and supports pricing power to some extent.

Green Thumb's brands are strong as well. RYTHM, for example, ranks among the best-selling cannabis brands in the country. Dogwalker is also a top pre-roll brand.

Today's Change

(

-0.49

%) $

-0.04

Current Price

$

8.19

Potential catalysts What could propel Green Thumb to double in value over the next three years? The company has several potential catalysts.

The most obvious catalyst is federal reclassification of marijuana to a Schedule III drug (which reflects moderate to low potential for physical and psychological dependence). Importantly, rescheduling will remove the IRS Section 280E restrictions on cannabis companies' access to business tax deductions already available to most U.S. companies. This change could significantly boost Green Thumb's profits.

Federal reforms that open access for cannabis companies to traditional financial services could also light a fire beneath Green Thumb's stock. Although efforts such as the SAFE Banking Act haven't become law yet, the upcoming congressional elections could pave the way for passage in the not-too-distant future.

Gov. Josh Shapiro in Pennsylvania supports the legalization of recreational cannabis in his state. The state's legislature has rejected previous attempts to open a recreational marijuana market. However, the political winds could shift. If they do, Green Thumb is well-positioned to capitalize on a lucrative new opportunity in Pennsylvania.

Many multi-state operators are in precarious financial shape. We could see industry consolidation. Green Thumb, with its strong balance sheet, could acquire other companies at attractive valuations and possibly drive its earnings growth enough to help the stock deliver a 100% gain over the next three years.

There's one other possibility that I think could easily fuel a tremendous surge for Green Thumb. If the company is allowed to list its shares on a major U.S. stock exchange, its stock could realistically double, in my view.

One (green) thumb up All eight analysts surveyed by S&P Global (SPGI +0.51%) in April who cover Green Thumb rated the stock a "buy." The consensus 12-month price target reflects a potential upside of more than 130%. Analysts think this marijuana stock will double in a year, not three years as I predict.

Why am I not quite as bullish as they are? Valuation. Green Thumb's shares currently trade at roughly 41 times forward earnings. I think the stock will be a winner in the coming years, but I can only give it one green thumb up because of its price tag.

CHICAGO and VANCOUVER, British Columbia, May 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced that it has submitted applications to the U.S. Drug Enforcement Administration (“DEA”) to register certain state-licensed medical cannabis operations under the expedited registration pathway created in connection with the recent rescheduling of medical marijuana to Schedule III of the Controlled Substances Act.

“Schedule III changes the future of medical cannabis in America, and Green Thumb is ready for what comes next,” said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler. “Rescheduling recognizes what millions of patients have known for years, opens the door to more research, and begins to fix the punitive tax treatment that has held responsible operators back. By seeking DEA registration, Green Thumb is taking a practical step toward a more normalized, regulated federal industry. We look forward to discussing this milestone along with our first quarter results with investors this Wednesday, May 6.”

Green Thumb owns RISE Dispensaries across 14 U.S. markets and operates over 110 retail locations serving both medical patients and adult-use consumers. The Company manufactures and produces a leading and award-winning portfolio of branded products including RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s and Good Green.

First Quarter 2026 Earnings
Green Thumb will release its first quarter 2026 financial results after the market closes on Wednesday, May 6, 2026. A conference call and audio webcast will be held the same day at 5:00 p.m. Eastern Time / 4:00 p.m. Central Time to discuss results and answer questions.

Conference call: https://register-conf.media-server.com/register/BIda3caa0c54504f80b8e6b4f26b5f6ac3Audio webcast: https://edge.media-server.com/mmc/p/j2jak29q Participants can pre-register for their preferred method by using the link above and entering their contact information. Registrants will receive a phone number or webcast link and personalized PIN to listen in live. The recording will also be available after the call at https://investors.gtigrows.com/.

The Green Thumb investor presentation is also available at any time for more information on the Company. The presentation can be accessed at https://investors.gtigrows.com/news-events/events-presentations.

About Green Thumb Industries
Green Thumb Industries Inc. (“Green Thumb” or the “Company”) is a leading national cannabis consumer packaged goods company and retailer headquartered in Chicago, Illinois. The company manufactures and distributes a portfolio of branded cannabis products, some of which are licensed, including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon’s and Good Green. Green Thumb also owns and operates RISE Dispensaries, a rapidly growing national retail chain with over 100 locations. Green Thumb serves millions of patients and customers each year with a mission to promote well-being through the power of cannabis while giving back to the communities it serves. Established in 2014, Green Thumb has manufacturing facilities and retail stores across 14 U.S. markets, employing approximately 5,000 people. More information is available at https://investors.gtigrows.com/.

Cautionary Note Regarding Forward-Looking Information
This press release contains statements which may constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect,” or similar expressions and include information licensing with the U.S. Drug Enforcement Administration (“DEA”), future tax treatment, and other implications of DEA registration, as well as the timing of future earnings releases. The forward-looking information in this news release is based upon the expectations of future events which management believes to be reasonable. Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Green Thumb does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information in this news release is subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those expressed or implied. When considering these forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in Green Thumb’s public filings with the applicable securities regulatory authorities, including with the U.S. Securities and Exchange Commission on its website at www.sec.gov and with Canada’s SEDAR+ at www.sedarplus.ca, as well as on Green Thumb’s website at https://investors.gtigrows.com, including in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Investor Contact:
Andy Grossman
EVP, Capital Markets & Investor Relations
[email protected] 
310-622-8257

Media Contact:
GTI Communications
[email protected]
Source: Green Thumb Industries Inc.

CHICAGO and VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for the first quarter ended March 31, 2026. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”), and all currency is in U.S. dollars.

Highlights for the first quarter ended March 31, 2026:

Revenue of $300.2 million, an increase of 7.4% over the same period in the prior year.Cash at quarter end totaled $344.5 million.GAAP net income of $15.4 million or $0.07 per basic and diluted share.Normalized EBITDA of $93.5 million or 31.2% of revenue.Cash flow from operations of $76.0 million.Repurchased approximately 6.0 million of the Company's Subordinate Voting Shares for $33.3 million.Increased syndicated credit facility by $50.0 million.
Subsequent to Quarter End

Conditionally awarded a Texas Compassionate Use Program license for vertically integrated operations.Repurchased approximately 7.4 million additional Subordinate Voting Shares, bringing 2026 year-to-date repurchases to approximately 13.4 million Subordinate Voting Shares for approximately $77.7 million. Since initiating its share repurchase programs in September 2023, the Company has repurchased approximately 29.0 million shares for approximately $200.0 million.Submitted registration applications with the U.S. Drug Enforcement Administration for certain state-licensed medical cannabis operations following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act.
See definitions and reconciliation of non-GAAP measures elsewhere in this release.

Management Commentary

“The Green Thumb team delivered a strong start to 2026, with first quarter revenue of $300 million, Normalized EBITDA of $94 million and cash flow from operations of $76 million,” said Green Thumb Founder, Chairman, and Chief Executive Officer Ben Kovler. “The recent federal action to reschedule medical cannabis from Schedule I to Schedule III is a historic step forward for our business, for investors, and for the country. Our conviction in Green Thumb remains as strong as ever, as reflected in the approximately 13.4 million shares we have repurchased so far this year. As the landscape around us continues to evolve, our team remains focused on disciplined execution and building for the future.”

Green Thumb President Anthony Georgiadis added, “With medical cannabis now rescheduled, the resulting Section 280E relief for the medical portion of our business creates meaningful flexibility to reinvest in our operations, our people, and the communities we serve. Consumer demand for THC continues to rise, and rescheduling helps create a more practical framework for companies like Green Thumb to meet that demand responsibly while continuing to grow and scale our business. Our team is ready for this next chapter in cannabis, and we look forward to continuing to serve patients and consumers while keeping momentum at the federal level toward broader reform and legalization.”

First Quarter 2026 Financial Overview

Total revenue for the first quarter was $300.2 million, up 7.4% from the prior year period. Overall retail revenue increased 4.7% versus the first quarter of 2025. Revenue growth in the first quarter was driven by retail sales in Minnesota, reflecting our launch of adult-use sales in the state on September 17, 2025, as well as continued growth in existing markets, particularly Connecticut and Florida, partially offset by price compression and increased competition. First quarter 2026 same store comparable sales (stores open at least 12 months) decreased 0.5% versus the prior year on a base of 100 stores.

Consumer Packaged Goods' gross revenue for the first quarter decreased by 1.6% versus the prior year period, primarily due to price compression and increased competition, partially offset by the launch of adult-use sales in Minnesota.

Gross profit for the first quarter 2026 was $143.6 million or 47.9% of revenue, compared to $143.3 million or 51.3% of revenue over the prior year period. The decline in gross margin was primarily driven by brand license fees incurred in the current period and price compression as discussed above.

Total selling, general and administrative expenses for the first quarter 2026 were $102.9 million or 34.3% of revenue, compared to $100.8 million or 36.1% of revenue for the first quarter 2025. The increase in selling, general, and administrative expenses was primarily attributable to increased compensation costs during the year.

Total other income (expense) for the first quarter 2026 was $22.4 million versus ($2.8) million for the comparable period in the prior year. Excluding a one-time arbitration settlement of $17 million and income associated with the Company's related party equity method investment of $6.5 million, total other income (expense) would have been ($1.1) million.

Net income attributable to the Company for the first quarter 2026 was $15.4 million or $0.07 per basic and diluted share, up from net income of $8.3 million, or $0.04 per basic and diluted share, in the prior year period. The increase in net income attributable to the Company was primarily due to the one-time arbitration settlement and the Company's related party equity method investment, as discussed above.

In the first quarter 2026, EBITDA was $73.1 million or 24.4% of revenue, versus $71.9 million or 25.7% of revenue for the comparable prior year period. Normalized EBITDA, which excludes licensing fees paid, non-cash stock-based compensation of $10.5 million, and other non-operating adjustments of $0.9 million, was $93.5 million or 31.2% of revenue, up from $85.2 million or 30.5% of revenue for the first quarter 2025.

For additional information on the non-GAAP financial measures discussed above, see “Non-GAAP Financial Information” below.

Balance Sheet and Liquidity

As of March 31, 2026, current assets were $673.9 million, including cash and cash equivalents of $344.5 million. Total debt outstanding was $289.9 million, which includes $188.8 million of senior debt.

Total basic and diluted weighted average shares outstanding for the three months ended March 31, 2026, were 230.6 million shares and 231.8 million shares, respectively.

Capital Allocation

During the first quarter 2026, the Company repurchased approximately 6.05 million Subordinate Voting Shares for a total amount of approximately $33.3 million, at an average price of $5.51 per share.

Subsequent to quarter end, the Company repurchased approximately 7.4 million additional Subordinate Voting Shares, bringing total repurchases since initiating its share repurchase program to approximately 29.0 million shares for approximately $200.0 million.

Non-GAAP Financial Information

This press release includes certain non-GAAP financial measures as defined by the U.S. Securities and Exchange Commission. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with generally accepted accounting principles (“GAAP”) are included in the financial schedules attached to this press release. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.

Definitions

EBITDA: Earnings before interest, taxes, other income or expense and depreciation and amortization.

Adjusted EBITDA: Earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash stock-based compensation, one-time transaction related expenses, or other non-operating costs.

Normalized EBITDA: Adjusted EBITDA plus brand license fees.

About Green Thumb Industries

Green Thumb Industries Inc. (“Green Thumb” or the “Company”) is a leading national cannabis consumer packaged goods company and retailer headquartered in Chicago, Illinois. The company manufactures and distributes a portfolio of branded cannabis products, some of which are licensed, including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon’s, and Good Green. Green Thumb also owns and operates RISE Dispensaries, a rapidly growing national retail chain with over 110 locations. Green Thumb serves millions of patients and customers each year with a mission to promote well-being through the power of cannabis while giving back to the communities it serves. Established in 2014, Green Thumb has manufacturing facilities and retail stores across 14 U.S. markets, employing approximately 4,900 people. More information is available at https://gtigrows.com/.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements that we believe are, or may be considered to be, “forward-looking statements.” All statements other than statements of historical fact included in this document regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “intend,” “estimate,” “foresee,” “opportunity,” “project,” “potential,” “risk,” “anticipate,” “believe,” “plan,” “forecast,” “continue,” “suggests” or “could” or the negative of these terms or variations of them or similar terms or expressions of similar meaning. Furthermore, forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission (the “SEC”), or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These known and unknown risks include, without limitation: cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change; future state regulation of cannabis is uncertain; the Company may not be able to obtain or maintain necessary permits and authorizations; the Company may face limitations on ownership of cannabis licenses; the Company may become subject to U.S. Food and Drug Administration or the U.S. Bureau of Alcohol, Tobacco, Firearms, and Explosives regulation; as a cannabis business, the Company is subject to applicable anti-money laundering laws and regulations and have restricted access to banking and other financial services; the Company may face difficulties acquiring additional financing; the Company operates in a highly regulated sector and may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where it conducts business; the Company faces intense competition; the Company faces competition from the illicit market as well as hemp products that are actually or purportedly compliant with the Agricultural Improvement Act of 2018 (the Farm Bill); the Company is dependent upon the popularity and consumer acceptance of its brand portfolio that the Company licenses from a third party; the Company has limited trademark protections; as a cannabis business, the Company is subject to unfavorable tax treatment and may incur significant tax liability; as a cannabis business, the Company may be subject to civil asset forfeiture; the Company is subject to proceeds of crime statutes; the Company faces exposure to fraudulent or illegal activity; the Company faces risks due to industry immaturity or limited comparable, competitive or established industry best practices; the Company faces risks related to its products; the Company’s business is subject to the risks inherent in agricultural operations; the Company faces an inherent risk of product liability and similar claims; the Company’s products may be subject to product recalls; the Company may face unfavorable publicity or consumer perception; the Company may be adversely impacted by rising or volatile energy costs and availability; the Company faces risks related to its information technology systems and potential cyber-attacks and security breaches; the Company relies on third-party software providers for numerous capabilities we depend upon to operate, and a disruption of one or more of these systems could adversely affect our business; the Company relies on the expertise of its management team and other employees experienced in the cannabis industry, and the loss of key personnel could negatively affect its business; the Company’s voting control is concentrated; the Company’s capital structure and voting control may cause unpredictability; and sales of substantial amounts Subordinate Voting Shares by the Company’s shareholders in the public market may have an adverse effect on the market price of the Company’s Subordinate Voting Shares. Further information on these and other potential factors that could affect the Company’s business and financial condition and the results of operations are included in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and elsewhere in the Company’s filings with the SEC, which are available (or will become available) on the SEC’s website, and on the Company’s SEDAR+ profile at www.sedarplus.ca, and at https://investors.gtigrows.com. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this document, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this document.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Investor Contacts:

Media Contact:
GTI Communications
[email protected]

Source: Green Thumb Industries Inc.

Highlights from Unaudited Interim Condensed Consolidated Statements of Operations
For the Three Months Ended March 31, 2026 and 2025
(Amounts Expressed in Thousands of United States Dollars, Except for Share Amounts)

  Three Months Ended  March 31, 2026 March 31, 2025  (Unaudited) (Unaudited)     Revenues, Net of Discounts $300,190  $279,540 Cost of Goods Sold  (156,545)  (136,265)     Gross Profit  143,645   143,275      Expenses:    Total Expenses  102,911   100,793      Income From Operations  40,734   42,482      Other Income (Expense):    Other Income (Expense), Net  22,967   (24)Interest Income  4,603   2,123 Interest Expense, Net  (5,165)  (4,865)     Total Other Income (Expense)  22,405   (2,766)     Income Before Provision for Income Taxes And Non-Controlling Interest 63,139   39,716      Provision For Income Taxes  48,092   31,315      Net Income Before Non-Controlling Interest  15,047   8,401      Net (Loss) Income Attributable To Non-Controlling Interest  (350)  95      Net Income Attributable To Green Thumb Industries Inc.$15,397  $8,306      Net Income Per Share - Basic $0.07  $0.04      Net Income Per Share - Diluted $0.07  $0.04      Weighted Average Number of Shares Outstanding - Basic  230,596,682   236,120,511      Weighted Average Number of Shares Outstanding - Diluted  231,827,061   236,822,468           Green Thumb Industries Inc.
Highlights from the Unaudited Interim Condensed Consolidated Balance Sheet
(Amounts Expressed in Thousands of United States Dollars)

 March 31, 2026 (Unaudited)Cash and Cash Equivalents$344,512Other Current Assets 329,338Property and Equipment, Net 686,499Right of Use Assets, Net 237,728Intangible Assets, Net 424,108Goodwill 591,764Other Long-term Assets 217,657Total Assets$2,831,606Total Current Liabilities$194,155Notes Payable, Net of Current Portion and Debt Discount 266,344Lease Liabilities, Net of Current Portion 253,463Other Long-Term Liabilities 220,595Total Equity 1,897,049Total Liabilities and Equity$2,831,606    Green Thumb Industries Inc. 
Supplemental Information (Unaudited) Regarding Non-GAAP Financial Measures
For the Three Months Ended March 31, 2026 and 2025
(Amounts Expressed in Thousands of United States Dollars)

EBITDA and Adjusted EBITDA are non-GAAP measures and do not have standardized definitions under GAAP. We define each term as follows:

(1) EBITDA is defined as earnings before interest, taxes, other income or expense and depreciation and amortization.
(2) Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating (income) or costs.
(3) Normalized EBITDA is defined as Adjusted EBITDA plus brand license fees.

The following information provides reconciliations of the supplemental non-GAAP financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-GAAP financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believes that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented.

  Three Months Ended  March 31, 2026 March 31, 2025  (Unaudited) (Unaudited)Net Income Before Noncontrolling Interest (GAAP) $15,047  $8,401 Interest Income  (4,603)  (2,123)Interest Expense, Net  5,165   4,865 Provision for Income Taxes  48,092   31,315 Other (Income) Expense, net  (22,967)  24 Depreciation and Amortization  32,413   29,411 Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) (non-GAAP measure) $73,147  $71,893 Share-based Compensation, Non-Cash  10,517   10,309 Acquisition, Transaction, and Other Non-Operating (Income) Costs  870   3,045 Adjusted EBITDA (non-GAAP measure) $84,534  $85,247      License Fee recorded in Cost of Sales  8,978   — Normalized EBITDA (Non-GAAP Measure) $93,512  $85,247 

Green Thumb Industries reported strong Q1-2026 results last week with increasing revenue and improved net income. The company will benefit from the rescheduling of medical cannabis in the US. GTBIF stock price is up 35% over the last year.

For years, cannabis investors have waited for one catalyst capable of fundamentally changing the economics of the U.S. marijuana industry.

That wait may soon be over.

The Drug Enforcement Administration (DEA) rescheduled cannabis from a Schedule I substance to a Schedule III substance last month. This is a very big deal (Schedule 1 drugs are considered extremely dangerous with no medical use, while Schedule III substances are considered less dangerous and has some medical uses.)

The biggest immediate impact would be relief from Internal Revenue Service tax rule 280E, which currently prevents cannabis companies from deducting many normal business expenses from income.

For multi-state cannabis operators already generating hundreds of millions in revenue, that could dramatically improve profitability and free cash flow almost overnight. And two specific marijuana stocks stand out as potential winners: Green Thumb Industries (GTBIF 0.49%) and Curaleaf Holdings (CURLF 0.81%).

But which stock could benefit the most?

Green Thumb may already have the strongest financial foundation Green Thumb enters this potential rescheduling cycle from a position of unusual financial strength for the cannabis industry.

The company generated $1.2 billion in 2025 revenue, along with $348.4 million in normalized EBITDA (earnings before interest, taxes, depreciation, and amortization) and nearly $295 million in operating cash flow.

Even more important, Green Thumb remains consistently profitable under generally accepted accounting principles (GAAP) -- something very few major cannabis operators can claim.

In Q1 2026, Green Thumb reported:

Revenue of $300.2 million GAAP net income of $15.4 million Normalized EBITDA of $93.5 million Cash balance of $344.5 million Its normalized EBITDA margin reached 31%, which remains among the strongest in the U.S. cannabis industry.

This isn't a trivial data point because DEA rescheduling will likely amplify existing strengths.

Today's Change

(

-0.49

%) $

-0.04

Current Price

$

8.19

Green Thumb already operates efficiently despite the crushing burden of 280E taxes. Removing part of that burden could significantly expand earnings and cash generation.

Management has already openly discussed the opportunity, noting that rescheduling and resulting 280E relief will create "meaningful flexibility" to reinvest into operations and future growth.

The company also continues aggressively buying back stock. Since September 2023, Green Thumb has repurchased roughly 29 million shares for about $200 million. That's unusual in cannabis, where many competitors remain heavily dependent on equity sales that lead to dilution and debt refinancing.

Curaleaf has more scale and possibly more upside Curaleaf may not be as consistently profitable as Green Thumb, but it remains the largest cannabis operator in the world by revenue.

In Q1 2026, Curaleaf generated $324.2 million in revenue, including $47 million from international operations, which rose 35% year over year. Adjusted EBITDA reached $63.4 million with a 19.6% margin.

The company also recently refinanced debt through a new $500 million senior secured notes offering due in 2029.

But Curaleaf's biggest advantage may be its international footprint.

While Green Thumb remains heavily concentrated in the U.S., Curaleaf has been expanding aggressively into Europe, particularly Germany, where medical cannabis growth continues accelerating. The company recently acquired full ownership of its German subsidiary, Four 20 Pharma.

That diversification could become increasingly important if U.S. reform progresses slowly or inconsistently.

Today's Change

(

-0.81

%) $

-0.09

Current Price

$

10.35

At the same time, Curaleaf's margins remain meaningfully narrower than Green Thumb's, and the company still carries a more leveraged balance sheet, meaning the company relies more heavily on debt to fund growth and operations. That can boost returns when business is strong, but it also increases risk because those debt payments still have to be made even when cash flow weakens, or the industry hits a downturn.

That creates a different type of opportunity, though.

If 280E tax relief substantially improves industrywide profitability, companies with weaker margins and larger tax burdens could potentially see the biggest percentage improvement in earnings.

In other words, Curaleaf may have more operating leverage.

Image source: Getty Images.

Green Thumb looks like the safer execution story.

The company already generates strong cash flow, maintains one of the best balance sheets in cannabis, and has demonstrated consistent operational discipline during an extremely difficult period for the industry. Now that the DEA has rescheduled cannabis, Green Thumb could emerge as one of the clearest long-term institutional winners.

Curaleaf, however, may offer the higher-risk, higher-reward setup.

Its larger scale, international exposure, and historically lower profitability mean rescheduling could potentially create a more dramatic earnings swing if tax burdens fall substantially and capital access improves.

Both companies could benefit enormously from more complete federal reform, such as national legalization. But if you're looking for the cannabis stock best positioned to capitalize on DEA rescheduling immediately, Green Thumb appears to have the stronger foundation.

Procter & Gamble (PG +0.32%) is known for its steady earnings growth and family of well-known consumer brands. While it's hard to compare a nearly 190-year-old consumer goods company to one in the nascent cannabis sector, Green Thumb Industries (GTBIF 0.49%) seems to be copying the classic P&G playbook.

To begin with, both companies are profitable, though Green Thumb doesn't have the long history of profitability that P&G has. How else are the two companies alike? 

They have dedicated portfolios of brands Just as Procter & Gamble doesn't sell generic soap -- it markets Tide, Dawn, and Pampers to target certain demographics -- Green Thumb avoids selling unbranded cannabis. It has built a diversified portfolio of consumer brands designed to capture different market segments and price points. They include vapes, edibles, pre-rolled products, and medical-grade products.

By segmenting the market this way, Green Thumb has been able to build brand loyalty rather than competing purely on wholesale price.

Today's Change

(

-0.49

%) $

-0.04

Current Price

$

8.19

They focus on consistent product performance Historically, the cannabis industry has been plagued by erratic product quality due to agricultural inconsistencies. Procter & Gamble's multi-decade success relies on a simple promise: Every bottle of Crest or Head & Shoulders will perform exactly like the last one.

Green Thumb invests heavily in scaled, highly standardized production facilities, operating 20 manufacturing hubs across 14 U.S. markets. This allows it to achieve consistent formulations, predictable potencies, and reliable flavor profiles across multi-state operations -- a foundational requirement to build a true brand.

Financial discipline and blue chip real estate Many multi-state operators (MSOs) in cannabis grew too quickly, taking on massive, high-interest debt loads to expand. Green Thumb has behaved more like a traditional consumer staple giant by prioritizing capital allocation, maintaining positive net income, and preserving a remarkably healthy balance sheet compared to its peers.

In the first quarter, Green Thumb reported revenue of $300.2 million, an increase of 7.4% year over year, and earnings per share (EPS) of $0.07, up from $0.04 last year. The company has $289.9 million in total debt, but $344.5 million in cash and cash equivalents.

If you compare Green Thumb to other large pure-play cannabis companies such as Curaleaf, Cresco Labs, and Trulieve, it has a superior debt-to-equity ratio and lower long-term debt.

Green Thumb focuses heavily on limited-license states, including Illinois, Pennsylvania, Ohio, and Maryland. By securing retail footprints and manufacturing capacity in states that limit the number of market participants, Green Thumb builds a defensive moat against infinite competition, maintaining pricing power much like Procter & Gamble commands prime shelf space in grocery aisles.

Image source: Getty Images.

Don't take the comparison too far While the operational comparison fits, the structural reality is vastly different. P&G enjoys cheap capital, frictionless interstate shipping, and massive institutional investment. It is a Dividend King, one of the rare group of stocks that have increased their dividends for 50 or more consecutive years. The yield is above-average at nearly 3%, and it raised its dividend by 3% this year, the 70th consecutive year it has increased it.

Despite its strong cash position and expanding credit facilities, Green Thumb doesn't offer a dividend yet, and it still operates in a federally illegal landscape. Its shares also trade over-the-counter, and until just recently, the company faced heavy tax burdens under IRS Section 280E. However, the recent U.S. federal reclassification of cannabis to Schedule III will be a massive looming catalyst for its balance sheet.

Key Takeaways Curaleaf announced a 1-for-3 reverse split as part of preparations for a potential U.S. exchange uplisting.CURLF posted Q1 2026 revenue growth of 6%, with international revenues rising 35% year over year.Curaleaf expects higher Q2 revenues and continued international growth but faces pricing pressure. Curaleaf Holdings  recently took another significant step toward a potential uplisting to a major U.S. stock exchange by announcing a 1-for-3 reverse stock split. The move follows the company’s earlier domestication plan and comes amid growing momentum behind federal cannabis reform efforts in the United States.

Why Uplisting Could Be a Game Changer for CURLFThe reverse stock split is the latest step in Curaleaf's broader effort to position itself for a potential U.S. stock exchange listing. Earlier this year, the company announced plans to domesticate from Canada to Delaware, aligning its corporate structure more closely with U.S. capital markets and laying the groundwork for a future uplisting.

While the reverse split does not change Curaleaf's underlying business or market value, a successful uplisting could have meaningful implications for the stock. Currently, many institutional investors are restricted from investing in cannabis operators that trade on over-the-counter (OTC) markets, limiting the pool of potential shareholders. A listing on a major U.S. exchange could improve liquidity, enhance visibility and attract a broader range of investors.

The timing is also notable. Curaleaf's latest move comes as federal cannabis reform efforts continue to gain momentum. Recently, the Department of Justice moved certain state-licensed medical cannabis products to Schedule III and initiated a broader review process for marijuana rescheduling. Management believes these developments could eventually improve access to banking and other financial services while supporting the industry's long-term growth prospects.

Taken together, the Delaware domestication plan and reverse stock split suggest that Curaleaf is actively preparing for a scenario in which regulatory barriers begin to ease. Although an uplisting is not guaranteed, the company seems committed to placing itself in a strong position if the opportunity eventually arises.

However, investors should look beyond these developments and evaluate Curaleaf's broader fundamentals to determine how to play the stock following this announcement.

Curaleaf's Business Shows Signs of ImprovementEarlier this month, the company reported first-quarter 2026 revenues of $324.2 million, up 6% year over year, driven by continued growth across both its domestic and international operations. International revenues increased 35% from the prior-year period, highlighting the strength of Curaleaf's expanding presence in European medical cannabis markets.

Management pointed to improving trends in several key markets. Florida, one of Curaleaf's most important states, delivered 15% transaction growth during the quarter, helping offset continued pricing pressure. The company has also continued expanding its retail footprint, recently opening two additional medical dispensaries in Florida and bringing its total store count in the state to 73 and 165 nationwide.

Looking ahead, management expects second-quarter revenues to increase 2-3% sequentially, implying revenues of roughly $333 million at the midpoint. The company also expects operating cash flow to strengthen as the year progresses and remains optimistic about international growth, where revenues are projected to increase 25-30% in 2026. Stabilizing pricing trends and ongoing product innovation could provide additional support for future growth.

Yet, challenges remain. Gross margin during the quarter was 49%, down 220 basis points over the year-ago period, as pricing pressure continued to weigh on the industry. While management noted that price compression has begun to stabilize in certain markets, profitability across the cannabis sector remains highly dependent on regulatory developments and market-specific supply dynamics.

Although the company’s bottom line swung to a surprising profit during the quarter, investors should note that the results benefited from the release of previously recorded tax reserves following a review of certain tax positions. As a result, the quarter's profitability may not fully reflect the company's underlying operating performance.

Cutthroat CompetitionCuraleaf operates in an increasingly competitive cannabis industry, where several multi-state operators are also positioning themselves to benefit from potential regulatory reform and improved access to capital markets.

Among its largest U.S. competitors is Green Thumb (GTBIF - Free Report) , which has built one of the strongest retail footprints in the U.S. cannabis market and has generally demonstrated greater consistency in profitability. As federal cannabis reform efforts advance, GTBIF is also expected to be among the key beneficiaries of improved access to capital and potential exchange uplisting opportunities.

On the international front, CURLF faces competition from Tilray Brands (TLRY - Free Report) , which operates across Europe, Canada and several emerging cannabis markets. TLRY has been aggressively expanding its international cannabis footprint, particularly in Europe, as it seeks to capitalize on the growing adoption of medical cannabis across the region. This expanding presence could intensify competition in a market that Curaleaf views as a key long-term growth driver.

CURLF Stock Performance and EstimatesYear to date, shares of Curaleaf Holdings have risen 41% against the industry’s 24% decline.

Image Source: Zacks Investment Research

Movements in loss estimates for 2026 and 2027 have been mixed over the past 30 days.

Image Source: Zacks Investment Research

How to Play CURLF Stock?Curaleaf appears to be making meaningful progress on multiple fronts. The company's efforts to prepare for a potential U.S. exchange uplisting, coupled with improving business trends and strong international growth, have strengthened the investment case for the stock.

It is important for investors to recognize that marijuana reclassification is unfolding gradually rather than through a rapid federal shift. Even if reforms continue to advance, several restrictions surrounding U.S. cannabis businesses are likely to remain in place, meaning the path toward broader industry normalization could take longer than investors expect.

Curaleaf operates in a highly competitive industry, facing pressure from well-established U.S. operators such as Green Thumb as well as internationally focused players like Tilray. Given the regulatory uncertainty and competitive landscape, investors may want to adopt a wait-and-watch approach toward the stock. Those considering an investment in this Zacks Rank #3 (Hold) company should exercise caution and closely monitor both regulatory developments and its ability to sustain recent operational momentum.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

A sea change is taking place for cannabis companies, one that will have an enormous benefit for the industry.

In April, the Department of Justice (DOJ) rescheduled medical marijuana from a Schedule I drug, similar to heroin or LSD, to a Schedule III substance, such as anabolic steroids for prescribed medical use and some commonly prescribed medicines, such as codeine mixed with acetaminophen.

The change means that medical marijuana will no longer be illegal at the federal level, and that change means that cannabis companies that sell medical marijuana will now be able to take standard business deductions, which they couldn't do previously under 280E of the Internal Revenue tax code.

The second shoe to drop regarding reclassification comes June 29, when hearings begin to determine if adult-use marijuana should also be rescheduled as a Schedule II substance. That would open up even more tax reductions for cannabis companies that also have adult-use sales.

Image source: Getty Images.

Even the reclassification isn't a done deal yet. The attorneys general of three states -- Indiana, Louisiana, and Nebraska -- filed a federal court petition in Washington, D.C. on May 22, claiming the DOJ's order violates federal administrative law and international drug-control treaties.

The final outcome remains uncertain, particularly regarding how unpaid past Section 280E tax liabilities -- currently carried as liabilities rather than debt -- will be resolved. Additionally, there is still no definitive progress on the SAFER Banking Act or the potential for stock exchange uplisting.

While shares of two of the largest multi-state operators, Trulieve (TCNNF 1.73%) and Curaleaf (CURLF 0.81%) have soared more than 90% and 70%, respectively, over the past three months, there are other cannabis stocks that are better buys right now and are less risky, with better debt positions: Green Thumb Industries (GTBIF 0.49%) and Tilray Brands (TLRY 1.76%).

Why I like Green Thumb Industries Green Thumb has a similarly large scale as Trulieve and Curaleaf, with 110 RISE dispensaries across 14 markets, but a better track record of financial discipline. The company has turned a profit in six of the past seven quarters, something neither Trulieve nor Curaleaf can claim.

Today's Change

(

-0.49

%) $

-0.04

Current Price

$

8.19

In the first quarter, Green Thumb reported revenue of $300.2 million, an increase of 7.4% year over year, and earnings per share of $0.07, an increase of 75% from the same quarter a year ago. The company has $289.9 million in total debt, but $344.5 million in cash and cash equivalents.

The company has done a good job of building up its brands, which helps insulate it from the price compression affecting the industry. The company's brands include RYTHM, Dogwalkers, Incredibles, Beboe, &Shine, Doctor Solomon's, and Good Green.

Why I like Tilray Brands Tilray, based in Canada, has an international presence, with operations in Canada, Europe, and the U.S. beverage market. Changes in U.S. regulations would allow Tilray to expand in the U.S., and a more favorable tax environment here could boost its revenue and earnings.

Today's Change

(

-1.76

%) $

-0.09

Current Price

$

5.03

Tilray already has a toehold in the U.S. Following strategic acquisitions -- including an expansive portfolio of craft beer brands from Anheuser-Busch and its acquisition of BrewDog -- Tilray has shielded itself from pure cannabis volatility. This infrastructure gives it an instant, legally compliant distribution network into U.S. retail and bars, which can be easily leveraged for THC- and CBD-infused beverages when federal laws shift, as well as give it a base to eventually operate cannabis sales in the U.S. The company already said it is looking into a pilot Center for Medicare and Medicaid Innovation program that would let it supply hemp-derived medical cannabis to patients through specific healthcare groups and cancer clinics.

The company is coming off a record third quarter, in which revenue grew 11% year over year to $206.7 million, including 73% growth in international sales.

Tilray also trimmed its total debt by 6% to $549 million. Management reconfirmed positive full-year adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance of $62 million to $72 million, representing growth of 13% to 31%, proving that its underlying operations are scaling effectively.

Tilray is a hidden gem The stock, because it doesn't yet sell cannabis in the U.S., is being overlooked compared to other large cannabis retailers. However, due to its growth in international sales and its marketing experience in the U.S. through its beverage sales, it has the wherewithal to pounce on new opportunities in the U.S.

The stock is priced right, with a price-to-sales ratio of 0.541, lower than Trulieve, Curaleaf, and Green Thumb Industries.

Green Thumb may still be the safer bet because it has a longer history of profitability, but Tilray offers several overlooked advantages and greater growth potential.

Cannabis Market Leaders to Watch in June 2026

5 minute read Top 3 Marijuana Stocks to Watch in June 2026 The cannabis sector continues evolving as operators focus on profitability, cash flow, and market expansion. Federal cannabis reform discussions remain a major catalyst. Meanwhile, leading multistate operators continue strengthening their positions across key U.S. markets. Investors searching for cannabis exposure may want to focus on companies with strong retail footprints and improving financial performance.

Three companies stand out heading into June 2026. Trulieve Cannabis, Curaleaf Holdings, and Green Thumb Industries have established national brands and significant operating scale. Additionally, all three companies recently reported encouraging financial results. Their ability to generate revenue and maintain profitability could make them attractive stocks to watch during the coming months.

[Read More] 3 Cannabis Stocks That Could Outperform in June 2026

Top 3 Marijuana Stocks to Watch in June 2026 Trulieve Cannabis (OTC: TCNNF) Curaleaf Holdings (OTC: CURLF) Green Thumb Industries (OTC: GTBIF) Trulieve Cannabis (OTC: TCNNF) Trulieve Cannabis remains one of the largest cannabis operators in the United States. The company built its reputation through its dominant position in Florida. Florida remains Trulieve’s largest market and serves as the foundation of its retail strategy. The company has steadily expanded into other states while maintaining a strong presence in the Southeast. As of May 2026, Trulieve operated approximately 240 dispensaries nationwide. Its retail network reaches customers across several key cannabis markets. Additionally, the company operates extensive cultivation and processing facilities throughout the country.

Trulieve focuses heavily on vertically integrated operations. This approach helps control product quality and improve margins. Furthermore, the company has developed several popular in-house brands. These brands generate customer loyalty and repeat purchases. Trulieve continues investing in retail growth while improving operational efficiency. The company also benefits from strong brand recognition among medical cannabis patients. As cannabis regulations evolve, Trulieve remains positioned to capitalize on future opportunities. Its large footprint and established infrastructure provide a competitive advantage. Therefore, many investors consider the company a leading cannabis stock for long-term growth.

Latest Financials Financially, Trulieve delivered a strong start to 2026. First-quarter revenue reached approximately $287 million. Gross margin came in at 59%, demonstrating operational efficiency. The company also reported positive net income of approximately $2 million. Adjusted EBITDA totaled roughly $100 million. Additionally, operating cash flow reached approximately $56 million. Free cash flow exceeded $42 million during the quarter. These results reflected management’s focus on profitability and cost discipline. Trulieve also ended the quarter with a substantial cash position. Revenue remained primarily driven by retail sales. Furthermore, the company benefited from improving industry conditions and regulatory developments. Full-year 2025 revenue reached approximately $1.2 billion. The company also generated record operating cash flow during 2025. Strong cash generation provides flexibility for future expansion. Therefore, Trulieve appears well-positioned heading into the second half of 2026. Investors will continue monitoring revenue growth and margin performance closely.

[Read More] Best Marijuana Stocks to Watch for Potential Upside in June 2026

Curaleaf Holdings (OTC: CURLF) Curaleaf remains one of the largest cannabis companies in North America. The company operates a broad footprint spanning numerous states and international markets. Its strongest presence is concentrated in major cannabis markets, including Florida, New York, and several northeastern states. Curaleaf has focused on building a nationally recognized cannabis brand. The company serves both medical and adult-use consumers. Additionally, Curaleaf offers a diverse portfolio of cannabis products. These products include flower, concentrates, edibles, and wellness offerings.

The company operates approximately 150 dispensaries across the United States. Its retail presence provides access to millions of potential consumers. Furthermore, Curaleaf continues expanding product distribution beyond company-owned stores. This strategy increases market penetration while supporting brand growth. Management has also pursued international opportunities. These efforts provide additional long-term growth potential. Curaleaf’s large-scale operations create purchasing advantages and operational efficiencies. As a result, the company remains one of the most closely watched cannabis operators. Investors often view Curaleaf as a bellwether for the broader cannabis industry. Its national reach and diversified operations help reduce reliance on any single market.

Latest Financials Curaleaf reported encouraging first-quarter 2026 financial results. Net revenue reached approximately $324 million. This represented year-over-year growth of roughly 6%. Gross profit totaled approximately $157 million. Gross margin remained strong at approximately 49%. Additionally, the company reported net income of approximately $70 million. These results highlighted improved operational execution and financial discipline. Curaleaf also continued expanding its international business. International revenue contributed meaningfully to quarterly performance. Furthermore, management completed strategic initiatives that strengthened the company’s long-term outlook. Full-year 2025 results also demonstrated steady progress. Fourth-quarter revenue reached approximately $333 million. Operating cash flow remained positive throughout the year. The company continues emphasizing profitability and cash generation. This focus differentiates Curaleaf from many smaller cannabis operators. Investors will be watching future quarters for continued margin stability and revenue growth. If management maintains current momentum, Curaleaf could remain a leading cannabis stock throughout 2026.

[Read More]  3 Canadian Marijuana Stocks That Could Help You Make Money

Green Thumb Industries (OTC: GTBIF) Green Thumb Industries has established itself as one of the most respected operators in the cannabis industry. The company operates under several well-known consumer brands. Additionally, Green Thumb owns the RISE dispensary chain. Illinois remains one of the company’s most important markets. However, Green Thumb operates in numerous states. Its retail network continues expanding in both medical and adult-use markets. The company operates approximately 100 dispensaries nationwide. Green Thumb has built a reputation for disciplined growth and operational excellence. Furthermore, management consistently emphasizes profitability rather than rapid expansion. This strategy has attracted many long-term investors.

The company’s product portfolio includes premium flower, edibles, concentrates, and wellness products. Green Thumb also benefits from strong consumer brand recognition. Its vertically integrated model helps support consistent product quality. Additionally, the company continues investing in cultivation and manufacturing capabilities. These investments strengthen its competitive position. As more states expand cannabis programs, Green Thumb remains well-positioned for growth. Its balanced approach to expansion and profitability makes it one of the industry’s strongest operators. Therefore, GTBIF remains a stock that many cannabis investors continue to monitor closely.

Latest Financials Green Thumb delivered another solid quarter in early 2026. First-quarter revenue reached approximately $300 million. This represented year-over-year growth of roughly 7.4%. The company also reported net income of approximately $15 million. Normalized EBITDA totaled approximately $94 million. Furthermore, operating cash flow reached approximately $76 million. Green Thumb ended the quarter with more than $340 million in cash. This strong balance sheet supports future growth opportunities. Management also repurchased shares during the quarter. Share repurchases demonstrate confidence in the company’s outlook. Additionally, Green Thumb expanded its credit facility. These actions improve financial flexibility. Full-year 2025 revenue reached approximately $1.2 billion. Revenue growth was supported by the expansion of retail operations and new market opportunities. Despite industry pricing pressure, Green Thumb maintained profitability. This performance highlights the strength of its operating model. Investors will continue watching revenue growth, cash generation, and margin trends throughout 2026. Strong financial execution could help GTBIF remain a leader in the cannabis sector.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | [email protected]

A month has gone by since the last earnings report for Oceaneering International (OII - Free Report) . Shares have lost about 3.1% in that time frame, outperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Oceaneering International due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Oceaneering International, Inc. before we dive into how investors and analysts have reacted as of late.

Oceaneering Q4 Earnings Surpass Estimates, Revenues MissOceaneering International reported an adjusted profit of 45 cents per share for the fourth quarter of 2025, beating the Zacks Consensus Estimate of 44 cents. Moreover, the bottom line surpassed the year-ago quarter’s reported figure of 37 cents. This was driven by strong year-over-year operating income from its Subsea Robotics, Manufactured Products and Aerospace and Defense Technologies segments.

Total revenues were $668.6 million, which missed the Zacks Consensus Estimate of $711 million and decreased approximately 6.3% from the year-ago quarter’s $713.5 million due to lower revenues in the company’s energy-focused businesses. The revenue decrease in the energy business was primarily due to the unusually high number of international intervention and installation projects that OII’s Offshore Projects Group segment performed in the prior-year quarter, but that did not repeat in the fourth quarter of 2025. In the fourth quarter of 2025, the Houston, TX-based oil and gas equipment and services company reported adjusted EBITDA of $90.5 million, a 10.9% decrease year over year.

The company also repurchased 419,005 shares for approximately $10.1 million in the fourth quarter of 2025.

Segmental InformationSubsea Robotics (SSR): The unit provides remotely operated submersible vehicles for drill support, vessel-based inspection, subsea hardware installation, pipeline surveys and maintenance services.

Revenues totaled $211.7 million compared with the year-ago quarter’s $212.2 million. However, the top line missed our estimate of $225 million.

The segment also reported an operating income of $67.8 million compared with $63.5 million a year ago. The figure beat our estimate of $65 million.

The company’s segment delivered an EBITDA margin of 38% in the fourth quarter of 2025, improving from the prior-year period’s 36%. Revenue per day for remotely operated vehicles (“ROVs”) rose 7% to $11,550, while ROV fleet utilization declined to 62%.

Manufactured Products: The segment focuses on the manufactured products business, theme park entertainment systems and automated guided vehicles.

Revenues totaled $132.4 million compared with the year-ago quarter’s $143 million. Additionally, the top line missed our estimate of $140 million.

The segment posted an operating profit of $20.4 million in the fourth quarter, up from the year-ago quarter’s $4.2 million. The reported figure beat our estimate of $9.4 million.

The backlog totaled $511 million as of Dec. 31, 2025, down 15.4% from the same time in 2024. For the 12 months ending Dec. 31, 2025, the book-to-bill ratio was 0.84.

Offshore Projects Group (OPG): This segment involves Oceaneering’s former Subsea Projects unit, excluding survey services and global data solutions, the service and rental business and ROV tooling.

Revenues decreased about 29.1% to $130.8 million from $184.4 million in the year-ago quarter. Moreover, the figure missed our estimate of $161 million.

The unit’s operating income totaled $15 million compared with the prior-year quarter’s $39.3 million. The figure also missed our estimate of $28.7 million. The company’s operating income margin decreased to 11% from the prior-year quarter’s 21%.

Integrity Management & Digital Solutions (IMDS): This segment covers Oceaneering’s Asset Integrity unit, along with its global data solutions business.

Revenues of $66.5 million decreased from the year-ago quarter’s $75.1 million. The figure also missed our estimate of $72 million.

The segment reported an operating loss of $0.12 million, reversing the prior-year quarter’s operating profit of $2 million. Moreover, the figure missed our projection of a profit of $0.65 million.

Aerospace and Defense Technologies (ADTech): The segment is engaged in Oceaneering’s government business, which focuses on defense subsea technologies, marine services and space systems.

Revenues totaled $127.3 million, up from $98.8 million recorded in the fourth quarter of 2024. The figure beat our estimate of $113 million.

The operating income increased to $14.2 million from $9.9 million in the year-ago quarter. However, it missed our estimate of $16.6 million. Operating income margin improved to 11%.

Capital Expenditure & Balance SheetThe capital expenditure in the fourth quarter, including acquisitions, totaled $36 million.

As of Dec. 31, 2025, OII had cash and cash equivalents worth $688.9 million and $497.5 million, respectively, along with a long-term debt of about $487.4 million. The debt-to-capitalization was 31.2%.

OutlookThe company anticipates lower revenues in the first quarter of 2026 compared with the same period in 2025. This is because of lower activity levels in energy markets at the start of 2026. The company anticipates consolidated EBITDA will be between $80 million and $90 million.

For SSR, the company expects a modest year-over-year uptick in revenues, while operating income is likely to decline due to shifts in geographic mix.

For Manufactured products, OII expects significantly higher operating income despite lower revenues.

For OPG, the company anticipates a significant decrease in revenues and operating income due to year-over-year changes in volume and project mix.

For IMDS, it expects both revenues and operating income to be relatively flat year over year

For ADTech, OII anticipates revenues to grow strongly, while operating income is projected to rise slightly due to changes in project mix.

During the first quarter of 2026, Oceaneering’s unallocated expenses are projected to be around the $50 million mark, driven by wage inflation, higher IT spending, and foreign exchange fluctuations.

For the full-year 2026, Oceaneering expects consolidated revenues to grow in the low to mid-single-digit percentage range. The company projects EBITDA of $390 million to $440 million, representing a modest increase at the midpoint versus 2025. Free cash flow is forecast at $100 million to $120 million, with the year-over-year decline reflecting the early receipt of approximately $37 million in customer payments in the fourth quarter of 2025. Combined 2025-2026 cash conversion is expected to be nearly 40%. Organic capital expenditures are projected at $105 million to $115 million, with 40% allocated to growth and 60% to maintenance. Energy-focused capex is expected to decline 12%, while ADTech spending increases. Net interest expense is forecast at $21 million to $26 million, and cash tax payments are expected at $95 million to $105 million.

Segmentally, SSR revenues are expected to grow in the low to mid-single digits, with EBITDA margins in the mid-30% range. ROV fleet utilization is projected in the mid-60% range, drill-support mix at 65%, and market share at 55% to 60%. Manufactured Products and OPG operating income margins are expected in the mid-teens, IMDS margins in the mid-single digits, and ADTech margins in the low teens. Unallocated expenses are anticipated at approximately $50 million per quarter.

How Have Estimates Been Moving Since Then?Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.

The consensus estimate has shifted -6.25% due to these changes.

VGM ScoresCurrently, Oceaneering International has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a D. However, the stock has a grade of B on the value side, putting it in the second quintile for value investors.

Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook Oceaneering International has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

HOUSTON--(BUSINESS WIRE)--Oceaneering Schedules First Quarter 2026 Earnings Release and Conference Call: April 22 and April 23, respectively.

Key Takeaways OII is set to report Q1 results on April 22 with an EPS of 35 cents and $664M revenue estimates.OII sees strength from 7% ROV pricing gains, $3.7B orders and 1.33 book-to-bill, boosting visibility.OII faces headwinds from weak energy demand, lower vessel use and working capital outflows. Oceaneering International, Inc. (OII - Free Report) is set to report first-quarter 2026 earnings on April 22, after the closing bell. The Zacks Consensus Estimate for earnings is pegged at 35 cents per share and the same for revenues is pinned at $664 million.

Let us delve into the factors that might have influenced OII’s performance in the to-be-reported quarter. Before that, it is worth taking a look at the company’s performance in the last reported quarter.

Highlights of OII’s Q4 EarningsIn the last reported quarter, the Houston, TX-based oil and gas equipment and services company’s earnings beat the consensus mark. OII reported an adjusted profit of 45 cents per share, beating the Zacks Consensus Estimate of 44 cents. This was driven by strong year-over-year operating income from its Subsea Robotics, Manufactured Products and Aerospace and Defense Technologies segments. However, revenues of $668.6 million missed the Zacks Consensus Estimate of $711 million.

OII’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average positive surprise of 17.3%.

This is depicted in the graph below:

OII Stock’s Trend in Estimate RevisionThe Zacks Consensus Estimate for first-quarter 2026 earnings has remained unchanged in the past 30 days. The estimated figure indicates an 18.6% year-over-year decrease. However, the Zacks Consensus Estimate for revenues implies a decrease of 1.6% from the year-ago period’s actual.

Factors to Consider Ahead of OII’s Q1 ResultsOceaneering International enters the first quarter of 2026 with strong operational momentum and improved pricing across key segments, particularly in Subsea Robotics, where remotely operated vehicle (ROV) pricing rose by about 7% and margins expanded. The company’s record $3.7 billion order intake and solid 1.33 book-to-bill ratio provide strong revenue visibility. Growth in the high-margin ADTech segment, backed by robust defense spending and a multiyear backlog, is expected to lift revenues. Additionally, continued backlog conversion in Manufactured Products and margin improvements across segments support profitability. Strong cash generation and a healthy $689 million cash balance enhance financial flexibility, positioning the company well to outperform expectations despite seasonal softness in the quarter to be reported.

Despite underlying strength, OII’s first quarter faces notable headwinds that could pressure results. Management expects consolidated revenues to decline sequentially due to weaker energy market activity early in the year, with offshore demand remaining subdued. A significant cash flow drag is anticipated from working capital outflows, as prior early customer payments in the fourth quarter of 2025 reduce first-quarter inflows. Offshore Projects Group is expected to see sharp declines in both revenues and operating income due to lower vessel utilization and a shift away from high-margin installation work. Additionally, flat-to-lower utilization in ROV operations and geographic mix impacts could weigh on margins. Elevated unallocated expenses and seasonal softness may further limit earnings upside.

What Does Our Model Predict for OII?Our proven model does not predict an earnings beat for Oceaneering International this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that is not the case here.

OII’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

OII’s Zacks Rank: OII currently carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks to ConsiderHere are some firms from the energy space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.

Liberty Energy Inc. (LBRT - Free Report) currently has an Earnings ESP of +3.85% and a Zacks Rank of 3.

LBRT is scheduled to release first-quarter 2026 earnings on April 22. The Zacks Consensus Estimate for LBRT’s 2026 revenues indicates 0.2% year-over-year growth.Valued at around $4.3 billion, the company’s shares have surged 127.9% in a year.

Patterson-UTI Energy, Inc. (PTEN - Free Report) presently has an Earnings ESP of +11.1% and a Zacks Rank #1. The firm is scheduled to release first-quarter 2026 earnings on April 22.

PTEN’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed in one, delivering a positive average surprise of 43%. Valued at around $3.6 billion, PTEN’s shares have jumped 60.2% in a year.

Enterprise Products Partners L.P. (EPD - Free Report) currently has an Earnings ESP of +1.91% and a Zacks Rank of 2. It is scheduled to release its first-quarter 2026 earnings on April 28.

The Zacks Consensus Estimate for EPD’s 2026 earnings per share indicates 7.1% year-over-year growth. Valued at around $79.3 billion, EPD’s shares have gained 22% in a year.

Posted by Defense World Staff on Apr 23rd, 2026

Oceaneering International, Inc. (NYSE:OII – Get Free Report)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as $39.49 and last traded at $38.4940, with a volume of 1537470 shares changing hands. The stock had previously closed at $37.82.

Analysts Set New Price Targets OII has been the subject of a number of recent analyst reports. Weiss Ratings upgraded Oceaneering International from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, February 23rd. Wall Street Zen cut shares of Oceaneering International from a “buy” rating to a “hold” rating in a research note on Sunday, March 1st. Barclays boosted their target price on shares of Oceaneering International from $23.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Monday, February 23rd. Zacks Research cut shares of Oceaneering International from a “strong-buy” rating to a “hold” rating in a research note on Thursday, March 5th. Finally, TD Cowen boosted their target price on shares of Oceaneering International from $28.00 to $34.00 and gave the stock a “hold” rating in a research note on Tuesday, March 3rd. One analyst has rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $33.67.

Read Our Latest Analysis on OII

Oceaneering International Price Performance The company has a quick ratio of 1.72, a current ratio of 1.99 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $3.84 billion, a PE ratio of 11.00 and a beta of 1.18. The company has a 50-day moving average of $35.64 and a 200 day moving average of $29.12.

Oceaneering International (NYSE:OII – Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The oil and gas company reported $0.30 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.05). Oceaneering International had a return on equity of 21.58% and a net margin of 12.71%.The firm had revenue of $692.43 million for the quarter, compared to analysts’ expectations of $671.35 million. During the same quarter in the previous year, the firm posted $0.43 earnings per share. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. Sell-side analysts predict that Oceaneering International, Inc. will post 1.93 EPS for the current year.

Insider Activity at Oceaneering International In related news, COO Benjamin Laura sold 5,106 shares of the company’s stock in a transaction dated Thursday, February 26th. The shares were sold at an average price of $36.88, for a total transaction of $188,309.28. Following the completion of the sale, the chief operating officer owned 40,805 shares of the company’s stock, valued at approximately $1,504,888.40. This represents a 11.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Earl Childress sold 22,518 shares of the company’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $37.41, for a total transaction of $842,398.38. Following the sale, the senior vice president directly owned 35,577 shares of the company’s stock, valued at approximately $1,330,935.57. This represents a 38.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 111,689 shares of company stock worth $4,204,360 in the last 90 days. 1.30% of the stock is owned by insiders.

Institutional Trading of Oceaneering International Large investors have recently bought and sold shares of the business. Salomon & Ludwin LLC acquired a new stake in shares of Oceaneering International in the 3rd quarter worth $26,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Oceaneering International in the 3rd quarter worth $28,000. EverSource Wealth Advisors LLC increased its stake in shares of Oceaneering International by 335.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,442 shares of the oil and gas company’s stock worth $30,000 after acquiring an additional 1,111 shares during the last quarter. Quarry LP acquired a new stake in shares of Oceaneering International in the 3rd quarter worth $30,000. Finally, SBI Securities Co. Ltd. increased its stake in shares of Oceaneering International by 255.1% in the 3rd quarter. SBI Securities Co. Ltd. now owns 1,392 shares of the oil and gas company’s stock worth $34,000 after acquiring an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 93.93% of the company’s stock.

About Oceaneering International (Get Free Report)

Oceaneering International, Inc is a global provider of engineered services and products primarily to the offshore oil and gas industry, as well as to aerospace, defense, and commercial diving markets. The company specializes in remotely operated vehicles (ROVs), subsea intervention, and inspection services designed to support exploration, production and maintenance activities in challenging underwater environments. In addition to ROV operations, Oceaneering offers asset integrity solutions, specialized tooling, and intervention equipment for pipelines, risers, and flowlines.

Founded in 1964 and headquartered in Houston, Texas, Oceaneering has grown through both organic expansion and strategic acquisitions.

Featured Articles Five stocks we like better than Oceaneering International Receive News & Ratings for Oceaneering International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oceaneering International and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEInterDigital (IDCC) Expected to Announce Quarterly Earnings on Thursday

NEXT HEADLINE »Mastercard (MA) Expected to Announce Quarterly Earnings on Thursday

Key Takeaways Oceaneering reported Q1 EPS of 30 cents, missing estimates, while revenues rose 2.7% to $692.4M.OII saw profit pressure from weaker Offshore Projects and IMDS despite growth in key segments.Oceaneering expects stronger Q2, with higher revenue and EBITDA forecast at $100M-$110M. Oceaneering International, Inc. (OII - Free Report) reported an adjusted profit of 30 cents per share for the first quarter of 2026, missing the Zacks Consensus Estimate of 35 cents. Moreover, the bottom line decreased from 43 cents in the year-ago quarter. This was due to lower operating income from its Offshore Projects Group and Integrity Management & Digital Solutions segments.

Total revenues were $692.4 million, which beat the Zacks Consensus Estimate of $664 million and increased approximately 2.7% from the year-ago quarter’s $674.5 million, driven by higher revenues in the company’s Subsea Robotics, Manufactured Products and Aerospace and Defense Technologies segments. In the first quarter of 2026, the Houston, TX-based oil and gas equipment and services company reported adjusted EBITDA of $83.7 million, a 13.4% decrease year over year.

Oceaneering International, Inc. Price, Consensus and EPS SurpriseQ1 Segmental Information of OceaneeringSubsea Robotics (SSR): The unit provides remotely operated submersible vehicles for drill support, vessel-based inspection, subsea hardware installation, pipeline surveys and maintenance services.

Revenues totaled $214.3 million compared with the year-ago quarter’s $206 million.

The segment also reported an operating income of $55.5 million compared with $59.6 million a year ago.

The company’s segment delivered an EBITDA margin of 32% in the first quarter of 2026, decreasing from the prior-year period’s 35%. Revenue per day for remotely operated vehicles (“ROVs”) rose to $12,401, while ROV fleet utilization declined to 61%.

Manufactured Products: The segment focuses on the manufactured products business, theme park entertainment systems and automated guided vehicles.

Revenues totaled $143.6 million compared with the year-ago quarter’s $135 million.

The segment posted an operating profit of $26.1 million in the first quarter, up from the year-ago quarter’s $8.7 million.

The backlog totaled $492 million as of March 31, 2026, down 9.4% from the same time in 2025. For the 12 months ending March 31, 2026, the book-to-bill ratio was 0.91.

Offshore Projects Group (OPG): This segment involves Oceaneering’s former Subsea Projects unit, excluding survey services and global data solutions, the service and rental business and ROV tooling.

Revenues decreased about 17.9% to $135.4 million from $164.9 million in the year-ago quarter.

The unit’s operating income totaled $18.3 million compared with the prior-year quarter’s $35.7 million. The company’s operating income margin decreased to 14% from the prior-year quarter’s 22%.

Integrity Management & Digital Solutions (IMDS): This segment covers Oceaneering’s Asset Integrity unit, along with its global data solutions business.

Revenues of $67.9 million decreased from the year-ago quarter’s $71.4 million.

The segment reported an operating loss of $0.99 million, reversing the prior-year quarter’s operating profit of $3.5 million.

Aerospace and Defense Technologies (ADTech): The segment is engaged in Oceaneering’s government business, which focuses on defense subsea technologies, marine services and space systems.

Revenues totaled $131.2 million, up from $97.1 million recorded in the first quarter of 2025.

The operating income decreased to $8.1 million from $10.7 million in the year-ago quarter. Operating income margin decreased to 6%.

OII’s Capital Expenditure & Balance SheetThe capital expenditure in the first quarter, including acquisitions, totaled $24.4 million.

As of March 31, 2026, OII had cash and cash equivalents worth $607.5 million and $688.9 million, respectively, along with a long-term debt of about $488.8 million. The debt-to-capitalization was 30.5%.

Q2 Outlook by OceaneeringThis Zacks Rank #3 (Hold) company expects stronger overall performance in the second quarter of 2026 compared to the same period in 2025, with consolidated revenues projected to rise and EBITDA estimated between $100 million and $110 million. Segment-wise, SSR is likely to see revenue growth but stable operating income, while Manufactured Products is forecasted to deliver increases in both revenues and profitability. OPG revenues are anticipated to remain steady, though operating income may dip slightly due to project mix changes. IMDS is expected to face declines in both revenue and earnings due to lower volumes in West Africa and Australia, along with uncertain activity in the Middle East. Meanwhile, ADTech is projected to post strong gains in operating income, supported by significantly higher revenues. Unallocated expenses are expected to be around $50 million.

The company has reaffirmed its full-year 2026 guidance at both the consolidated and segment levels, as previously outlined in its fourth-quarter 2025 earnings release and conference call. However, IMDS operating income is now expected to grow year over year at a more modest pace than earlier projected. The Manufactured Products segment is anticipated to report a full-year book-to-bill ratio in the range of 0.9 to 1.0.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Important Earnings at a GlanceWhile we have discussed OII’s first-quarter results in detail, let us take a look at three other key reports in this space.

Halliburton Company (HAL - Free Report) reported first-quarter 2026 adjusted net income per share of 55 cents, beating the Zacks Consensus Estimate of 49 cents. The outperformance primarily reflects successful cost reduction initiatives. However, the bottom line fell from the year-ago adjusted profit of 60 cents due to softer activity in the North American region and the negative impact of geopolitical conflict in the Middle East, which hurt both of the company’s segments.

Meanwhile, revenues of $5.4 billion were 0.3% lower year over year but beat the Zacks Consensus Estimate of $5.3 billion.

Halliburton reported first-quarter capital expenditure of $192 million. As of March 31, 2026, the company had approximately $2 billion in cash/cash equivalents and $7.1 billion in long-term debt, representing a debt-to-capitalization ratio of 39.6.

Range Resources Corporation (RRC - Free Report) reported first-quarter 2026 adjusted earnings of $1.52 per share, which beat the Zacks Consensus Estimate of $1.33. The bottom line also improved from the prior-year level of 96 cents.

Total quarterly revenues of $1,018.3 million topped the Zacks Consensus Estimate of $919.3 million. The top line increased from the prior-year figure of $854 million.

Strong quarterly results can be attributed to higher gas-equivalent production and increased natural gas price realization.

At the end of the first quarter, Range Resources reported a total debt of $819.3 million, net of deferred financing costs.

EQT Corporation (EQT - Free Report) reported first-quarter 2026 adjusted earnings from continuing operations of $2.33 per share, which beat the Zacks Consensus Estimate of $2.23. The bottom line increased from the year-ago quarter’s figure of $1.18.

Adjusted operating revenues increased to $3,136 million from $2,153 million in the prior-year quarter. The top line beat the Zacks Consensus Estimate of $3,127 million.

Strong quarterly results were driven by the increase in total sales volumes and higher realized natural gas equivalent prices.

As of March 31, 2026, the company had cash and cash equivalents of $326.6 million and net debt of $5.67 billion.

Oceaneering International is rated a 'Buy', with a 13% upside driven by robust defense demand and service-based contract focus. ADTech segment revenues surged 35% YoY, now comprising nearly 20% of OII's Q1 2026 revenues, offsetting energy segment weakness. The company guides for FY 2026 revenue growth of 5% YoY and EBITDA of $415 million, with ROV daily revenue expected to reach ~$13,000.

On May 14, 2026, Archon Capital Management disclosed a new position in Oceaneering International (OII 1.51%), acquiring 208,000 shares in a transaction estimated at $6.73 million based on quarterly average pricing.

What happenedAccording to a SEC filing dated May 14, 2026, Archon Capital Management initiated a new position in Oceaneering International by purchasing 208,000 shares. The estimated transaction value, based on average share pricing during the first quarter, was $6.73 million. The quarter-end value of the stake reached $7.38 million, a figure that incorporates both share acquisition and subsequent price appreciation.

What else to knowTop five holdings after this filing:NASDAQ:BAND: $10.39 million (5.87% of AUM)NASDAQ:APYX: $10.30 million (5.8% of AUM)NYSE:SVV: $9.65 million (5.45% of AUM)NASDAQ:BRZE: $9.51 million (5.37% of AUM)NASDAQ:OMDA: $9.11 million (5.1% of AUM)As of Thursday, Oceaneering International shares were priced at $38.48, up nearly 105% over the past year and well outperforming the S&P 500, which is instead up about 27% in the same period.Company OverviewMetricValueRevenue (TTM)$2.80 billionNet Income (TTM)$339.49 millionMarket Capitalization$4 billionPrice (as of market close 2026-05-14)$38.48Company SnapshotOceaneering International provides engineered services, subsea robotics, manufactured products, and digital solutions for the offshore energy, defense, aerospace, manufacturing, and entertainment sectors.The firm generates revenue through subsea robotics operations, manufactured products for energy and industrial clients, offshore project services, and asset integrity management and digital solutions.It serves global energy companies, government agencies, aerospace and defense contractors, and industrial clients with a focus on offshore and subsea applications.Oceaneering International, Inc. operates at scale with a diversified portfolio spanning subsea robotics, engineered products, and digital solutions, supporting critical operations in the offshore energy and defense sectors. The company leverages advanced robotics and engineering expertise to deliver integrated solutions for complex subsea and industrial challenges. Its broad customer base and technological capabilities provide a competitive edge in servicing high-specification, mission-critical projects worldwide.

What this transaction means for investorsOceaneering's stock has already more than doubled over the past year, and last quarter alone, shares skyrocketed nearly 50%. However, prices are still down nearly 50% from highs over a decade ago, suggesting Archon believes Oceaneering can add back at least some of that upside going forward. Fundamentally, the latest quarter was mixed on the surface. Revenue rose 3% year over year to $692 million, but net income fell 28% to $36 million, and adjusted EBITDA declined 13% to $83.7 million. Still, management pointed to roughly $1 billion in new orders during the quarter, including more than $300 million of Subsea Robotics awards extending as far as 2031 and $175 million of Aerospace and Defense Technologies awards.

What's especially interesting is where future growth may come from. Management continues to highlight its aerospace and defense business as its primary growth driver for 2026 while also expecting offshore activity to improve in the second half of the year. The company maintained full-year EBITDA guidance of $390 million to $440 million despite ongoing geopolitical disruptions in parts of its energy business.

For long-term investors, the story is increasingly about this diversification. The firm’s growing exposure to defense, robotics, and autonomous systems could give investors multiple ways to win if those markets continue expanding. And Archon seems a part of that camp.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Braze, Omada Health, and Savers Value Village. The Motley Fool recommends Bandwidth. The Motley Fool has a disclosure policy.

A month has gone by since the last earnings report for Oceaneering International (OII - Free Report) . Shares have added about 1.2% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Oceaneering International due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Oceaneering International, Inc. before we dive into how investors and analysts have reacted as of late.

Oceaneering Q1 Earnings Fall Short of Estimates, Revenues BeatOceaneering International reported an adjusted profit of 30 cents per share for the first quarter of 2026, missing the Zacks Consensus Estimate of 35 cents. Moreover, the bottom line decreased from 43 cents in the year-ago quarter. This was due to lower operating income from its Offshore Projects Group and Integrity Management & Digital Solutions segments.

Total revenues were $692.4 million, which beat the Zacks Consensus Estimate of $664 million and increased approximately 2.7% from the year-ago quarter’s $674.5 million, driven by higher revenues in the company’s Subsea Robotics, Manufactured Products and Aerospace and Defense Technologies segments. In the first quarter of 2026, the Houston, TX-based oil and gas equipment and services company reported adjusted EBITDA of $83.7 million, a 13.4% decrease year over year.

Q1 Segmental InformationSubsea Robotics (SSR): The unit provides remotely operated submersible vehicles for drill support, vessel-based inspection, subsea hardware installation, pipeline surveys and maintenance services.

Revenues totaled $214.3 million compared with the year-ago quarter’s $206 million.

The segment also reported an operating income of $55.5 million compared with $59.6 million a year ago.

The company’s segment delivered an EBITDA margin of 32% in the first quarter of 2026, decreasing from the prior-year period’s 35%. Revenue per day for remotely operated vehicles (“ROVs”) rose to $12,401, while ROV fleet utilization declined to 61%.

Manufactured Products: The segment focuses on the manufactured products business, theme park entertainment systems and automated guided vehicles.

Revenues totaled $143.6 million compared with the year-ago quarter’s $135 million.

The segment posted an operating profit of $26.1 million in the first quarter, up from the year-ago quarter’s $8.7 million.

The backlog totaled $492 million as of March 31, 2026, down 9.4% from the same time in 2025. For the 12 months ending March 31, 2026, the book-to-bill ratio was 0.91.

Offshore Projects Group (OPG): This segment involves Oceaneering’s former Subsea Projects unit, excluding survey services and global data solutions, the service and rental business and ROV tooling.

Revenues decreased about 17.9% to $135.4 million from $164.9 million in the year-ago quarter.

The unit’s operating income totaled $18.3 million compared with the prior-year quarter’s $35.7 million. The company’s operating income margin decreased to 14% from the prior-year quarter’s 22%.

Integrity Management & Digital Solutions (IMDS): This segment covers Oceaneering’s Asset Integrity unit, along with its global data solutions business.

Revenues of $67.9 million decreased from the year-ago quarter’s $71.4 million.

The segment reported an operating loss of $0.99 million, reversing the prior-year quarter’s operating profit of $3.5 million.

Aerospace and Defense Technologies (ADTech): The segment is engaged in Oceaneering’s government business, which focuses on defense subsea technologies, marine services and space systems.

Revenues totaled $131.2 million, up from $97.1 million recorded in the first quarter of 2025.

The operating income decreased to $8.1 million from $10.7 million in the year-ago quarter. Operating income margin decreased to 6%.

Capital Expenditure & Balance SheetThe capital expenditure in the first quarter, including acquisitions, totaled $24.4 million.

As of March 31, 2026, OII had cash and cash equivalents worth $607.5 million and $688.9 million, respectively, along with a long-term debt of about $488.8 million. The debt-to-capitalization was 30.5%.

Q2 OutlookThe company expects stronger overall performance in the second quarter of 2026 compared to the same period in 2025, with consolidated revenues projected to rise and EBITDA estimated between $100 million and $110 million. Segment-wise, SSR is likely to see revenue growth but stable operating income, while Manufactured Products is forecasted to deliver increases in both revenues and profitability. OPG revenues are anticipated to remain steady, though operating income may dip slightly due to project mix changes. IMDS is expected to face declines in both revenue and earnings due to lower volumes in West Africa and Australia, along with uncertain activity in the Middle East. Meanwhile, ADTech is projected to post strong gains in operating income, supported by significantly higher revenues. Unallocated expenses are expected to be around $50 million.

The company has reaffirmed its full-year 2026 guidance at both the consolidated and segment levels, as previously outlined in its fourth-quarter 2025 earnings release and conference call. However, IMDS operating income is now expected to grow year over year at a more modest pace than earlier projected. The Manufactured Products segment is anticipated to report a full-year book-to-bill ratio in the range of 0.9 to 1.0.

How Have Estimates Been Moving Since Then?Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.

VGM ScoresAt this time, Oceaneering International has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a score of B on the value side, putting it in the top 40% for value investors.

Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook Oceaneering International has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry PlayerOceaneering International is part of the Zacks Oil and Gas - Field Services industry. Over the past month, Halliburton (HAL - Free Report) , a stock from the same industry, has gained 5.8%. The company reported its results for the quarter ended March 2026 more than a month ago.

Halliburton reported revenues of $5.4 billion in the last reported quarter, representing a year-over-year change of -0.3%. EPS of $0.55 for the same period compares with $0.60 a year ago.

Halliburton is expected to post earnings of $0.54 per share for the current quarter, representing a year-over-year change of -1.8%. Over the last 30 days, the Zacks Consensus Estimate has changed +4.9%.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Halliburton. Also, the stock has a VGM Score of C.

Posted by Defense World Staff on Mar 29th, 2026

Getty Images Holdings, Inc. (NYSE:GETY – Get Free Report) VP Daine Marc Weston sold 12,928 shares of the business’s stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $0.78, for a total transaction of $10,083.84. Following the transaction, the vice president directly owned 142,159 shares of the company’s stock, valued at $110,884.02. The trade was a 8.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Getty Images Price Performance Shares of NYSE:GETY opened at $0.75 on Friday. The firm’s 50 day moving average is $0.96 and its two-hundred day moving average is $1.45. Getty Images Holdings, Inc. has a 52 week low of $0.67 and a 52 week high of $3.21. The firm has a market capitalization of $312.07 million, a P/E ratio of -1.49 and a beta of 2.13. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 2.12.

Getty Images (NYSE:GETY – Get Free Report) last issued its quarterly earnings data on Monday, March 16th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.25). Getty Images had a negative return on equity of 25.05% and a negative net margin of 21.00%.The business had revenue of $282.29 million for the quarter, compared to analyst estimates of $246.17 million. Analysts anticipate that Getty Images Holdings, Inc. will post 0.08 earnings per share for the current year.

Institutional Investors Weigh In On Getty Images A number of institutional investors have recently added to or reduced their stakes in GETY. Koch Inc. boosted its stake in Getty Images by 42.8% during the 4th quarter. Koch Inc. now owns 115,259,246 shares of the company’s stock valued at $154,447,000 after purchasing an additional 34,525,639 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Getty Images by 43.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 2,434,545 shares of the company’s stock worth $4,041,000 after buying an additional 742,008 shares in the last quarter. Readystate Asset Management LP acquired a new stake in shares of Getty Images in the fourth quarter valued at $3,071,000. Geode Capital Management LLC lifted its holdings in shares of Getty Images by 14.0% in the second quarter. Geode Capital Management LLC now owns 1,866,490 shares of the company’s stock valued at $3,099,000 after buying an additional 228,532 shares during the period. Finally, Millennium Management LLC boosted its stake in Getty Images by 160.7% during the fourth quarter. Millennium Management LLC now owns 1,530,821 shares of the company’s stock valued at $2,051,000 after buying an additional 943,567 shares in the last quarter. 45.75% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets Several research analysts have recently issued reports on GETY shares. Zacks Research cut Getty Images from a “hold” rating to a “strong sell” rating in a research note on Friday, March 20th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Getty Images in a report on Thursday, January 22nd. Finally, Citigroup decreased their target price on shares of Getty Images from $1.85 to $0.85 and set a “neutral” rating for the company in a research report on Monday, February 23rd. One analyst has rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $3.78.

View Our Latest Stock Report on Getty Images

Key Headlines Impacting Getty Images Here are the key news stories impacting Getty Images this week:

Neutral Sentiment: Recent fundamentals remain weak: Getty missed on EPS in its Mar. 16 quarter (reported ($0.22) vs. $0.03 expected) despite revenue above estimates; the company has negative margins and elevated debt-to-equity. MarketBeat: GETY fundamentals and earnings Negative Sentiment: CEO Craig Warren Peters sold 167,403 shares (~$130,574), reducing his stake ~11.5%. SEC Filing – Craig Peters sale Negative Sentiment: Grant Farhall sold 42,022 shares (~$32,777), trimming his holding by ~12.7%. SEC Filing – Grant Farhall sale Negative Sentiment: CMO Gene Foca and CFO Jennifer Leyden each sold 31,576 shares (~$24,629 each), reducing stakes by ~5.9% and ~9.1% respectively. SEC Filing – Gene Foca sale SEC Filing – Jennifer Leyden sale Negative Sentiment: SVPs Kenneth Arrigo Mainardis (29,565 shares) and Peter Orlowsky (22,081 shares) also sold portions of their stakes. SEC Filing – Kenneth Arrigo Mainardis sale SEC Filing – Peter Orlowsky sale Negative Sentiment: CTO Nathaniel Gandert sold 21,349 shares (~$16,652). SEC Filing – Nathaniel Gandert sale Negative Sentiment: Other insider sales: Cho Mikael (two transactions totaling 26,476 shares), Daine Marc Weston (12,928), and Michael Teaster (6,587). SEC Filings – Cho Mikael sales SEC Filing – Daine Marc Weston sale SEC Filing – Michael Teaster sale Getty Images Company Profile (Get Free Report)

Getty Images (NYSE: GETY) is a leading global provider of digital visual content, offering an extensive library of stock photography, editorial imagery, video footage and music. The company supplies creative and rights-managed assets to a broad range of industries, including advertising, media, corporate communications and publishing. Through its online platform and licensing services, Getty Images enables customers to search, license and download multimedia content for commercial and editorial use.

Founded in 1995 by Mark Getty and Jonathan Klein, Getty Images pioneered the aggregation of photographic archives into a centralized, digital marketplace.

Further Reading Five stocks we like better than Getty Images

Receive News & Ratings for Getty Images Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getty Images and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECypress Wealth Services LLC Increases Position in Vanguard Intermediate-Term Corporate Bond ETF $VCIT

NEXT HEADLINE »Inspired Entertainment (NASDAQ:INSE) CEO Brooks Pierce Acquires 1,668 Shares

Posted by Defense World Staff on Mar 29th, 2026

Getty Images Holdings, Inc. (NYSE:GETY – Get Free Report) CMO Gene Foca sold 31,576 shares of the business’s stock in a transaction that occurred on Wednesday, March 25th. The shares were sold at an average price of $0.78, for a total value of $24,629.28. Following the completion of the transaction, the chief marketing officer owned 507,651 shares of the company’s stock, valued at $395,967.78. This represents a 5.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Getty Images Price Performance NYSE GETY opened at $0.75 on Friday. The company has a debt-to-equity ratio of 2.12, a quick ratio of 0.77 and a current ratio of 0.77. The stock has a market cap of $312.07 million, a price-to-earnings ratio of -1.49 and a beta of 2.13. The business has a 50 day simple moving average of $0.96 and a 200 day simple moving average of $1.45. Getty Images Holdings, Inc. has a 52-week low of $0.67 and a 52-week high of $3.21.

Getty Images (NYSE:GETY – Get Free Report) last announced its quarterly earnings results on Monday, March 16th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.25). The company had revenue of $282.29 million during the quarter, compared to the consensus estimate of $246.17 million. Getty Images had a negative net margin of 21.00% and a negative return on equity of 25.05%. Analysts anticipate that Getty Images Holdings, Inc. will post 0.08 earnings per share for the current fiscal year.

Institutional Trading of Getty Images A number of institutional investors have recently made changes to their positions in GETY. Koch Inc. boosted its holdings in Getty Images by 42.8% during the fourth quarter. Koch Inc. now owns 115,259,246 shares of the company’s stock worth $154,447,000 after purchasing an additional 34,525,639 shares during the last quarter. Readystate Asset Management LP acquired a new stake in Getty Images in the 4th quarter valued at $3,071,000. Millennium Management LLC increased its stake in Getty Images by 160.7% in the 4th quarter. Millennium Management LLC now owns 1,530,821 shares of the company’s stock valued at $2,051,000 after buying an additional 943,567 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Getty Images by 43.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 2,434,545 shares of the company’s stock worth $4,041,000 after buying an additional 742,008 shares in the last quarter. Finally, Callodine Capital Management LP bought a new stake in Getty Images during the 4th quarter worth about $670,000. Institutional investors own 45.75% of the company’s stock.

Getty Images News Summary Here are the key news stories impacting Getty Images this week:

Neutral Sentiment: Recent fundamentals remain weak: Getty missed on EPS in its Mar. 16 quarter (reported ($0.22) vs. $0.03 expected) despite revenue above estimates; the company has negative margins and elevated debt-to-equity. MarketBeat: GETY fundamentals and earnings Negative Sentiment: CEO Craig Warren Peters sold 167,403 shares (~$130,574), reducing his stake ~11.5%. SEC Filing – Craig Peters sale Negative Sentiment: Grant Farhall sold 42,022 shares (~$32,777), trimming his holding by ~12.7%. SEC Filing – Grant Farhall sale Negative Sentiment: CMO Gene Foca and CFO Jennifer Leyden each sold 31,576 shares (~$24,629 each), reducing stakes by ~5.9% and ~9.1% respectively. SEC Filing – Gene Foca sale SEC Filing – Jennifer Leyden sale Negative Sentiment: SVPs Kenneth Arrigo Mainardis (29,565 shares) and Peter Orlowsky (22,081 shares) also sold portions of their stakes. SEC Filing – Kenneth Arrigo Mainardis sale SEC Filing – Peter Orlowsky sale Negative Sentiment: CTO Nathaniel Gandert sold 21,349 shares (~$16,652). SEC Filing – Nathaniel Gandert sale Negative Sentiment: Other insider sales: Cho Mikael (two transactions totaling 26,476 shares), Daine Marc Weston (12,928), and Michael Teaster (6,587). SEC Filings – Cho Mikael sales SEC Filing – Daine Marc Weston sale SEC Filing – Michael Teaster sale Wall Street Analyst Weigh In A number of brokerages recently weighed in on GETY. Zacks Research lowered shares of Getty Images from a “hold” rating to a “strong sell” rating in a research note on Friday, March 20th. Weiss Ratings reissued a “sell (d)” rating on shares of Getty Images in a research note on Thursday, January 22nd. Finally, Citigroup cut their price target on Getty Images from $1.85 to $0.85 and set a “neutral” rating on the stock in a report on Monday, February 23rd. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $3.78.

Read Our Latest Research Report on GETY

Getty Images Company Profile (Get Free Report)

Getty Images (NYSE: GETY) is a leading global provider of digital visual content, offering an extensive library of stock photography, editorial imagery, video footage and music. The company supplies creative and rights-managed assets to a broad range of industries, including advertising, media, corporate communications and publishing. Through its online platform and licensing services, Getty Images enables customers to search, license and download multimedia content for commercial and editorial use.

Founded in 1995 by Mark Getty and Jonathan Klein, Getty Images pioneered the aggregation of photographic archives into a centralized, digital marketplace.

Featured Stories Five stocks we like better than Getty Images

Receive News & Ratings for Getty Images Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getty Images and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEVinci Compass Investments (NASDAQ:VINP) Insider Fernando Lovisotto Sells 1,824 Shares

NEXT HEADLINE »Vinci Compass Investments (NASDAQ:VINP) Insider Fernando Lovisotto Sells 2,380 Shares of Stock

Posted by Defense World Staff on Mar 29th, 2026

Getty Images Holdings, Inc. (NYSE:GETY – Get Free Report) SVP Peter Orlowsky sold 22,081 shares of the stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $0.78, for a total value of $17,223.18. Following the transaction, the senior vice president directly owned 252,890 shares of the company’s stock, valued at approximately $197,254.20. This trade represents a 8.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Getty Images Stock Down 3.9% Getty Images stock opened at $0.75 on Friday. The company has a debt-to-equity ratio of 2.12, a current ratio of 0.77 and a quick ratio of 0.77. Getty Images Holdings, Inc. has a 1-year low of $0.67 and a 1-year high of $3.21. The company has a market cap of $312.07 million, a PE ratio of -1.49 and a beta of 2.13. The stock’s 50 day moving average price is $0.96 and its 200 day moving average price is $1.45.

Getty Images (NYSE:GETY – Get Free Report) last released its quarterly earnings data on Monday, March 16th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.25). Getty Images had a negative return on equity of 25.05% and a negative net margin of 21.00%.The business had revenue of $282.29 million during the quarter, compared to analysts’ expectations of $246.17 million. On average, sell-side analysts predict that Getty Images Holdings, Inc. will post 0.08 EPS for the current fiscal year.

Key Getty Images News Here are the key news stories impacting Getty Images this week:

Neutral Sentiment: Recent fundamentals remain weak: Getty missed on EPS in its Mar. 16 quarter (reported ($0.22) vs. $0.03 expected) despite revenue above estimates; the company has negative margins and elevated debt-to-equity. MarketBeat: GETY fundamentals and earnings Negative Sentiment: CEO Craig Warren Peters sold 167,403 shares (~$130,574), reducing his stake ~11.5%. SEC Filing – Craig Peters sale Negative Sentiment: Grant Farhall sold 42,022 shares (~$32,777), trimming his holding by ~12.7%. SEC Filing – Grant Farhall sale Negative Sentiment: CMO Gene Foca and CFO Jennifer Leyden each sold 31,576 shares (~$24,629 each), reducing stakes by ~5.9% and ~9.1% respectively. SEC Filing – Gene Foca sale SEC Filing – Jennifer Leyden sale Negative Sentiment: SVPs Kenneth Arrigo Mainardis (29,565 shares) and Peter Orlowsky (22,081 shares) also sold portions of their stakes. SEC Filing – Kenneth Arrigo Mainardis sale SEC Filing – Peter Orlowsky sale Negative Sentiment: CTO Nathaniel Gandert sold 21,349 shares (~$16,652). SEC Filing – Nathaniel Gandert sale Negative Sentiment: Other insider sales: Cho Mikael (two transactions totaling 26,476 shares), Daine Marc Weston (12,928), and Michael Teaster (6,587). SEC Filings – Cho Mikael sales SEC Filing – Daine Marc Weston sale SEC Filing – Michael Teaster sale Analysts Set New Price Targets GETY has been the subject of several recent analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Getty Images in a research note on Thursday, January 22nd. Citigroup lowered their target price on shares of Getty Images from $1.85 to $0.85 and set a “neutral” rating on the stock in a research report on Monday, February 23rd. Finally, Zacks Research downgraded shares of Getty Images from a “hold” rating to a “strong sell” rating in a research report on Friday, March 20th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus target price of $3.78.

Read Our Latest Analysis on Getty Images

Institutional Inflows and Outflows A number of hedge funds have recently made changes to their positions in GETY. State of Alaska Department of Revenue acquired a new position in shares of Getty Images during the 3rd quarter worth $25,000. Cerity Partners LLC acquired a new stake in Getty Images in the 2nd quarter valued at about $32,000. Certuity LLC acquired a new stake in Getty Images in the 4th quarter valued at about $33,000. Wealth Enhancement Advisory Services LLC increased its holdings in Getty Images by 47.2% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 15,870 shares of the company’s stock valued at $33,000 after acquiring an additional 5,089 shares in the last quarter. Finally, Founders Financial Securities LLC purchased a new position in Getty Images during the 4th quarter valued at about $35,000. Hedge funds and other institutional investors own 45.75% of the company’s stock.

Getty Images Company Profile (Get Free Report)

Getty Images (NYSE: GETY) is a leading global provider of digital visual content, offering an extensive library of stock photography, editorial imagery, video footage and music. The company supplies creative and rights-managed assets to a broad range of industries, including advertising, media, corporate communications and publishing. Through its online platform and licensing services, Getty Images enables customers to search, license and download multimedia content for commercial and editorial use.

Founded in 1995 by Mark Getty and Jonathan Klein, Getty Images pioneered the aggregation of photographic archives into a centralized, digital marketplace.

See Also Five stocks we like better than Getty Images

Receive News & Ratings for Getty Images Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getty Images and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEVinci Compass Investments (NASDAQ:VINP) CFO Sergio Passos Ribeiro Sells 1,035 Shares

NEXT HEADLINE »Vinci Compass Investments (NASDAQ:VINP) CFO Sergio Passos Ribeiro Sells 1,244 Shares of Stock

Posted by Defense World Staff on Mar 29th, 2026

Getty Images Holdings, Inc. (NYSE:GETY – Get Free Report) CFO Jennifer Leyden sold 31,576 shares of the company’s stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $0.78, for a total transaction of $24,629.28. Following the sale, the chief financial officer directly owned 316,780 shares of the company’s stock, valued at approximately $247,088.40. This trade represents a 9.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Getty Images Trading Down 3.9% NYSE:GETY opened at $0.75 on Friday. The business’s 50-day moving average is $0.96 and its two-hundred day moving average is $1.45. The firm has a market capitalization of $312.07 million, a PE ratio of -1.49 and a beta of 2.13. Getty Images Holdings, Inc. has a 12 month low of $0.67 and a 12 month high of $3.21. The company has a debt-to-equity ratio of 2.12, a current ratio of 0.77 and a quick ratio of 0.77.

Getty Images (NYSE:GETY – Get Free Report) last issued its earnings results on Monday, March 16th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.25). Getty Images had a negative return on equity of 25.05% and a negative net margin of 21.00%.The company had revenue of $282.29 million during the quarter, compared to analysts’ expectations of $246.17 million. Research analysts predict that Getty Images Holdings, Inc. will post 0.08 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth GETY has been the topic of a number of analyst reports. Citigroup dropped their price objective on shares of Getty Images from $1.85 to $0.85 and set a “neutral” rating on the stock in a research note on Monday, February 23rd. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Getty Images in a research note on Thursday, January 22nd. Finally, Zacks Research lowered shares of Getty Images from a “hold” rating to a “strong sell” rating in a report on Friday, March 20th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $3.78.

Check Out Our Latest Report on GETY

Getty Images News Roundup Here are the key news stories impacting Getty Images this week:

Neutral Sentiment: Recent fundamentals remain weak: Getty missed on EPS in its Mar. 16 quarter (reported ($0.22) vs. $0.03 expected) despite revenue above estimates; the company has negative margins and elevated debt-to-equity. MarketBeat: GETY fundamentals and earnings Negative Sentiment: CEO Craig Warren Peters sold 167,403 shares (~$130,574), reducing his stake ~11.5%. SEC Filing – Craig Peters sale Negative Sentiment: Grant Farhall sold 42,022 shares (~$32,777), trimming his holding by ~12.7%. SEC Filing – Grant Farhall sale Negative Sentiment: CMO Gene Foca and CFO Jennifer Leyden each sold 31,576 shares (~$24,629 each), reducing stakes by ~5.9% and ~9.1% respectively. SEC Filing – Gene Foca sale SEC Filing – Jennifer Leyden sale Negative Sentiment: SVPs Kenneth Arrigo Mainardis (29,565 shares) and Peter Orlowsky (22,081 shares) also sold portions of their stakes. SEC Filing – Kenneth Arrigo Mainardis sale SEC Filing – Peter Orlowsky sale Negative Sentiment: CTO Nathaniel Gandert sold 21,349 shares (~$16,652). SEC Filing – Nathaniel Gandert sale Negative Sentiment: Other insider sales: Cho Mikael (two transactions totaling 26,476 shares), Daine Marc Weston (12,928), and Michael Teaster (6,587). SEC Filings – Cho Mikael sales SEC Filing – Daine Marc Weston sale SEC Filing – Michael Teaster sale Institutional Trading of Getty Images Hedge funds have recently made changes to their positions in the stock. AQR Capital Management LLC raised its holdings in Getty Images by 1,201.6% in the first quarter. AQR Capital Management LLC now owns 275,296 shares of the company’s stock valued at $476,000 after acquiring an additional 254,146 shares in the last quarter. Geode Capital Management LLC boosted its stake in Getty Images by 14.0% during the 2nd quarter. Geode Capital Management LLC now owns 1,866,490 shares of the company’s stock valued at $3,099,000 after acquiring an additional 228,532 shares during the last quarter. Creative Planning acquired a new position in Getty Images during the 2nd quarter worth $75,000. Intech Investment Management LLC grew its holdings in Getty Images by 19.3% during the 2nd quarter. Intech Investment Management LLC now owns 68,843 shares of the company’s stock worth $114,000 after acquiring an additional 11,121 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Getty Images by 43.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 2,434,545 shares of the company’s stock worth $4,041,000 after purchasing an additional 742,008 shares during the last quarter. Institutional investors and hedge funds own 45.75% of the company’s stock.

Getty Images Company Profile (Get Free Report)

Getty Images (NYSE: GETY) is a leading global provider of digital visual content, offering an extensive library of stock photography, editorial imagery, video footage and music. The company supplies creative and rights-managed assets to a broad range of industries, including advertising, media, corporate communications and publishing. Through its online platform and licensing services, Getty Images enables customers to search, license and download multimedia content for commercial and editorial use.

Founded in 1995 by Mark Getty and Jonathan Klein, Getty Images pioneered the aggregation of photographic archives into a centralized, digital marketplace.

Featured Stories Five stocks we like better than Getty Images

Receive News & Ratings for Getty Images Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getty Images and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEInspired Entertainment (NASDAQ:INSE) Chairman A Lorne Weil Purchases 8,341 Shares

NEXT HEADLINE »Chesley Taft & Associates LLC Boosts Holdings in Palo Alto Networks, Inc. $PANW

Posted by Defense World Staff on Apr 8th, 2026

Rekor Systems (NASDAQ:REKR – Get Free Report) and Getty Images (NYSE:GETY – Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Profitability This table compares Rekor Systems and Getty Images’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets Rekor Systems -89.82% -126.37% -54.48% Getty Images -21.00% -25.05% -5.89% Analyst Ratings This is a breakdown of recent ratings and target prices for Rekor Systems and Getty Images, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rekor Systems 1 0 0 0 1.00 Getty Images 2 2 1 0 1.80 Getty Images has a consensus price target of $3.78, indicating a potential upside of 358.03%. Given Getty Images’ stronger consensus rating and higher probable upside, analysts plainly believe Getty Images is more favorable than Rekor Systems.

Valuation and Earnings This table compares Rekor Systems and Getty Images”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rekor Systems $48.45 million 2.22 -$61.41 million ($0.26) -3.03 Getty Images $981.29 million 0.35 -$206.12 million ($0.50) -1.65 Rekor Systems has higher earnings, but lower revenue than Getty Images. Rekor Systems is trading at a lower price-to-earnings ratio than Getty Images, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership 45.7% of Rekor Systems shares are owned by institutional investors. Comparatively, 45.8% of Getty Images shares are owned by institutional investors. 13.1% of Rekor Systems shares are owned by company insiders. Comparatively, 12.5% of Getty Images shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility and Risk Rekor Systems has a beta of 2, suggesting that its stock price is 100% more volatile than the S&P 500. Comparatively, Getty Images has a beta of 2.08, suggesting that its stock price is 108% more volatile than the S&P 500.

Summary Getty Images beats Rekor Systems on 10 of the 14 factors compared between the two stocks.

About Rekor Systems (Get Free Report)

Rekor Systems, Inc., a technology company, provides infrastructure solutions for transportation, public safety, and urban mobility markets in the United States and internationally. The company's platforms include Rekor One, an AI-powered roadway intelligence platform; Rekor Command, a comprehensive cross-agency platform that offers various applications for traffic management centers, freeway service patrol, first responders, and maintenance crews; Rekor Discover, a platform that ingests data from its hardware and automates comprehensive analytics and actionable insights about the movement of objects across the roadway; and Rekor Scout platform, which automates previously manual processes with collaborative solutions that keep all stakeholders apprised of developing situations and accelerate reaction times to incidents and offenders. It also offers Rekor AutoNotice, a cloud-based financial management application that delivers a turnkey information and citation management solution for cities, states, and municipalities for primary and secondary offenses; and Rekor CarCheck, which allows its AI based vehicle and license plate recognition technology to be accessed for a range of commercial applications. In addition, the company offers Rekor Edge Max System, a fixed traffic data collection system that captures and transforms roadway data into holistic traffic insights; Rekor Edge Pro, a vehicle recognition solution that is used on a standalone basis or integrated into a network; and Rekor Edge Flex, a portable data collection system. Further, it provides traffic services, including traditional traffic studies, which delivers data and insights for planning and management of roadway infrastructure and commercial initiatives; innovative AI-driven traffic studies for traffic management; and traffic engineering services. The company was incorporated in 2017 and is headquartered in Columbia, Maryland.

About Getty Images (Get Free Report)

Getty Images Holdings, Inc. offers creative and editorial visual content solutions in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Its products include Getty Images that offers creative and editorial content including stills, music and video which focuses on corporate, agency, and media customers; iStock.com, an e-commerce offering where customers have access to creative stills and video; Unsplash.com, a platform offering free stock photo downloads and paid subscriptions targeted to the high-growth prosumer and semi-professional creator segments; and Unsplash+ that provides access to unique model released content with expanded legal protections. In addition, it maintains privately-owned photographic archives covering news, sport, and entertainment, as well as variety of subjects, including lifestyle, business, science, health, wellness, beauty, sports, transportation, and travel. Further, the company provides music licensing, and digital asset management and distribution services. It serves media outlets, advertising agencies and corporations, individual creators, and prosumers. The company was formerly known as Getty Images, Inc. Getty Images Holdings, Inc. was founded in 1995 and is headquartered in Seattle, Washington.

Receive News & Ratings for Rekor Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rekor Systems and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlibaba Group Holding Limited (NYSE:BABA) Receives Consensus Rating of “Moderate Buy” from Brokerages

NEXT HEADLINE »Axalta Coating Systems Ltd. (NYSE:AXTA) Receives Consensus Recommendation of “Hold” from Analysts